Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Мочекаменная болезнь

Список литературы

  1. Strohmaier W. Epidemiologie und Pathogenese der Urolithiasis. Die Urologie. Part of the series Springer Reference Medizin. 2016: 473-478.
  2. Бакетин П.С., Моллаев Р.А., Д.А. Мазуренко, Григорьев В.Е. и соавт. Патогенетические варианты мочекаменной болезни. Педиатр. 2017; №8 (1):89-99.
  3. Coe F.L., Evan A.P., Worcester E.M., Lingeman J.E. Three pathways for human kidney stone formation. Urol Res. 2010; №38 (3):147-60. doi: 10.1007/s00240-010-0271-8.
  4. Evan A.P., Lingeman J., Coe F., Shao Y., Miller N., et al. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007; №71 (8):795-801.
  5. Kok D.J., Khan S.R. Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int. 1994; №46 (3):847-54.
  6. Белай С.И., Довбыш М.А., Белай И.М. Мочекаменная болезнь: актуальность вопроса и перспективы его развития. Вестник ВГМУ. Украина. 2016; №15 (5):19-26.
  7. Борисов В.В. Мочекаменная болезнь. Терапия больных камнями почек и мочеточников. М., 2011. с.96.
  8. Trinchieri A., Curhan G., Karlsen S., Jun Wu К. Epidemiology. Stone Disease. Paris: Health Publications, 2003; с.13–30.
  9. Stamatelou K.K., Francis M.E., Jones C.A., Nyberg L.M., Curhan G.C. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003; №63 (5):1817-23.
  10. Trinchieri A., Ostini F., Nespoli R., Rovera F., Montanari E., et al. A prospective study of recurrence rate and risk factors for recurrence after a first renal stone. J Urol. 1999; №162 (1):27-30.
  11. Rule A.D., Lieske J.C., Li X., Melton L.J.3rd., Krambeck A.E., et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol. 2014; №25 (12):2878-86.
  12. Гаджиев Н.К., Бровкин С.С., Григорьев В.Е., Дмитриев В.В., Малхасян В.А., и др. Метафилактика мочекаменной болезни: новый взгляд, современный подход, мобильная реализация. Урология. 2017; 1:124-129.
  13. Hesse A., Brändle E., Wilbert D., Köhrmann K.U., Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol. 2003; №44 (6):709-13.
  14. Leusmann D.B. Whewellite, weddellite and company: where do all the strange names originate? BJU Int. 2000; №86 (4):411-3.
  15. Leusmann D.B., Blaschke R., Schmandt W. Results of 5,035 stone analyses: a contribution to epidemiology of urinary stone disease. Scand J Urol Nephrol. 1990; №24 (3):205-10.
  16. Kim S.C., Burns E.K., Lingeman J.E., Paterson R.F., McAteer J.A., et al. Cystine calculi: correlation of CT-visible structure, CT number, and stone morphology with fragmentation by shock wave lithotripsy. Urol Res. 2007; №35 (6):319-24.
  17. Perlmutter A.E., Talug C., Tarry W.F., Zaslau S., Mohseni H., et al. Impact of stone location on success rates of endoscopic lithotripsy for nephrolithiasis. Urology. 2008; №71 (2):214-7.
  18. Eisner B.H., Reese A., Sheth S., Stoller M.L. Ureteral stone location at emergency room presentation with colic. J Urol. 2009; №182 (1):165-8.
  19. Segura J.W., Preminger G.M., Assimos D.G., Dretler S.P., Kahn R.I., et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. 1997; №158 (5):1915-21.
  20. Chung B.I., Aron M., Hegarty N.J., Desai M.M. Ureteroscopic versus percutaneous treatment for medium-size (1-2-cm) renal calculi. J Endourol. 2008; №22 (2):343-6.
  21. Keoghane S., Walmsley B. Hodgson D. The natural history of untreated renal tract calculi. BJU Int. 2010; №105 (12):1627-9.
  22. Straub M., Strohmaier W.L., Berg W., Beck B., Hoppe B., et al. Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline. World J Urol. 2005; №23 (5): с.309-23.
  23. Hesse A., Tiselius B.H., Siener S.R., et al. Urinary Stones, Diagnosis, Treatment and Prevention of Recurrence. 3rd edition. 2009, Basel.
  24. Basiri A., Shakhssalim N. Khoshdel A.R., Javaherforooshzadeh A., Basiri H., et al. Familial relations and recurrence pattern in nephrolithiasis: new words about old subjects. Urol J. 2010 №7(2):81-6.
  25. Goldfarb D.S., Fischer M.E., Keich Y., Goldberg J. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005; №67 (3):1053-61.
  26. Asplin J.R., Coe F.L. Hyperoxaluria in kidney stone formers treated with modern bariatric surgery. J Urol. 2007; №177 (2):565-9.
  27. Gonzalez R.D., Canales B.K. Kidney stone risk following modern bariatric surgery. Curr Urol Rep. 2014; №15 (5):401.
  28. Rendina D., De Filippo G., D"Elia L., Strazzullo P. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol. 2014; №27 (4):371-6.
  29. Dell"Orto V.G., Belotti E.A., Goeggel-Simonetti B., Simonetti G.D., Ramelli G.P., et al. Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review. Br J Clin Pharmacol. 2014; №77 (6):958-64.
  30. Mufti U.B., Nalagatla S.K. Nephrolithiasis in autosomal dominant polycystic kidney disease. J Endourol. 2010; №24 (10):1557-61.
  31. Chen Y., DeVivo M.J., Roseman J.M. Current trend and risk factors for kidney stones in persons with spinal cord injury: a longitudinal study. Spinal Cord. 2000; №38 (6):346-53.
  32. Hara A., Yang W.Y., Petit T., Zhang Z.Y., Gu Y.M., et al. Incidence of nephrolithiasis in relation to environmental exposure to lead and cadmium in a population study. Environ Res. 2016; №145:1-8.
  33. Wimpissinger F., Türk C., Kheyfets O., Stackl W. The silence of the stones: asymptomatic ureteral calculi. J Urol. 2007; №178 (4):1341-4.
  34. Türk C., Skolarikos A., Neisius A., Petřík A., Seitz C., Thomas K. EAU Guidelines. Urolithiasis. presented at the EAU Annual Congress Barcelona 2019. ISBN 978-94-92671-04-2.
  35. Plot C., Evliyaoglu O., Erkan REC., Başturk A., Tugrul Çakır., Aslaner A., et al. Comparison of urine microscopy and urine culture results of patients considered to have urinary tract infection. Am J Exp Clin Res. 2015; №2(3): 118-20.
  36. Parmar M.S. Kidney stones. BMJ. 2004; №328 (7453): 1420–1424.
  37. Miller N.L., Lingeman J.E. Management of kidney stones. BMJ. 2007; №334 (7591):468-72.
  38. Pearle M.S., Asplin J.R., Coe F.L., Rodregs A., Worcester E.M. Medical management of urolithiasis. 2nd International consultation on Stone Disease. Health Publications, 2008; 57-85.
  39. Matlaga BR, Shah OD, Assimos DG. Drug-induced urinary calculi. Rev Urol. 2003 Fall; № (4):227-31.
  40. G. Bonkat (Co-chair), R. Pickard (Co-chair), R. Bartoletti,, et al., EAU Guidelines on Urological Infections, in EAU Guidelines, Edn. published as the 32nd EAU Annual Meeting, London, E.A.o.U.G. Office, Editor. 2017, European Association of Urology Guidelines Office: Arnhem, The Netherlands.
  41. Gutierrez J., Smith A., Geavlete P., Shah H., Kural A.R., de Sio M., Amón Sesmero J.H., Hoznek A., de la Rosette J.; CROES PCNL Study Group. Urinary tract infections and post-operative fever in percutaneous nephrolithotomy. World J Urol. 2013; №31(5):1135-40.
  42. Worster A., Preyra I., Weaver B., Haines T. The accuracy of noncontrast helical computed tomography versus intravenous pyelography in the diagnosis of suspected acute urolithiasis: a meta-analysis. Ann Emerg Med. 2002; №40 (3):280-6.
  43. Miller O.F., Rineer S.K., Reichard S.R., Buckley R.G., Donovan M.S., et al. Prospective comparison of unenhanced spiral computed tomography and intravenous urogram in the evaluation of acute flank pain. Urology. 1998; №52 (6):982-7.
  44. Yilmaz S., Sindel T., Arslan G., Ozkaynak C., Karaali K., et al. Renal colic: comparison of spiral CT, US and IVU in the detection of ureteral calculi. Eur Radiol. 1998; №8 (2):212-7.
  45. Smith R.C., Rosenfield A.T., Choe K.A., Essenmacher K.R., Verga M., et al. Acute flank pain: comparison of non-contrast-enhanced CT and intravenous urography. Radiology. 1995; №194 (3):789-94.
  46. Pfister S.A., Deckart A., Laschke S., Dellas S., Otto U., et al. Unenhanced helical computed tomography vs intravenous urography in patients with acute flank pain: accuracy and economic impact in a randomized prospective trial. Eur Radiol. 2003; №13 (11):2513-20.
  47. Sheafor D.H., Hertzberg B.S., Freed K.S., Carroll B.A., Keogan M.T., et al. Nonenhanced helical CT and US in the emergency evaluation of patients with renal colic: prospective comparison. Radiology. 2000; №217(3):792-7.
  48. Smith-Bindman R., Aubin C., Bailitz J., Bengiamin R.N., Camargo C.A. Jr, et al. Ultrasonography versus computed tomography for suspected nephrolithiasis. N Engl J Med. 2014; №371 (12):1100-10.
  49. Levine J.A., Neitlich J., Verga M., Dalrymple N., Smith R.C. Ureteral calculi in patients with flank pain: correlation of plain radiography with unenhanced helical CT. Radiology. 1997; №204 (1):27-31.
  50. El-Nahas A.R., El-Assmy A.M., Mansour O., Sheir K.Z. A prospective multivariate analysis of factors predicting stone disintegration by extracorporeal shock wave lithotripsy: the value of high-resolution noncontrast computed tomography. Eur Urol. 2007; №51 (6):1688-93.
  51. Patel T., Kozakowski K., Hruby G., Gupta M. Skin to stone distance is an independent predictor of stone-free status following shockwave lithotripsy. J Endourol. 2009; №23 (9):1383-5.
  52. Zarse C.A., Hameed T.A., Jackson M.E., Pishchalnikov Y.A., Lingeman J.E., et al. CT visible internal stone structure, but not Hounsfield unit value, of calcium oxalate monohydrate (COM) calculi predicts lithotripsy fragility in vitro. Urol Res. 2007; №35 (4): 201-6.
  53. Schwartz B.F., Schenkman N., Armenakas N.A., Stoller M.L. Imaging characteristics of indinavir calculi. J Urol. 1999; №161 (4):1085-7.
  54. Sourtzis S., Thibeau J.F., Damry N., Raslan A., Vandendris M., et al. Radiologic investigation of renal colic: unenhanced helical CT compared with excretory urography. AJR Am J Roentgenol. 1999; №172 (6):1491-4.
  55. Niall O., Russell J., MacGregor R., Duncan H., Mullins J. A comparison of noncontrast computerized tomography with excretory urography in the assessment of acute flank pain. J Urol. 1999; №161 (2):534-7.
  56. Wang J.H., Shen S.H., Huang S.S., Chang C.Y. Prospective comparison of unenhanced spiral computed tomography and intravenous urography in the evaluation of acute renal colic. J Chin Med Assoc. 2008; №71 (1): 30-36.
  57. Shine S. Urinary calculus: IVU vs. CT renal stone? A critically appraised topic. Abdom Imaging. 2008; №33 (1): с.41-3.
  58. Ulusan S., Koc Z., Tokmak N. Accuracy of sonography for detecting renal stone: comparison with CT. J Clin Ultrasound. 2007; №35 (5): с.256-61.
  59. Caoili E.M., Cohan R.H., Korobkin M., Platt J.F., Francis I.R., Faerber G.J., Montie J.E., Ellis J.H. Urinary tract abnormalities: initial experience with multi-detector row CT urography. Radiology. 2002; №222 (2):353-60.
  60. Thomson J.M., Glocer J., Abbott C., Maling T.M., Mark S. Computed tomography versus intravenous urography in diagnosis of acute flank pain from urolithiasis: a randomized study comparing imaging costs and radiation dose. Australas Radiol. 2001; №45 (3):291-7.
  61. Poletti P.A. Platon A., Rutschmann O.T., Schmidlin F.R., Iselin C.E., et al. Low-dose versus standard-dose CT protocol in patients with clinically suspected renal colic. AJR Am J Roentgenol. 2007; №188 (4):927-33.
  62. Kluner C., Hein P.A., Gralla O., Hein E., Hamm B., et al. Does ultra-low-dose CT with a radiation dose equivalent to that of KUB suffice to detect renal and ureteral calculi? J Comput Assist Tomogr. 2006; №30 (1):44-50.
  63. Jellison F.C., Smith J.C., Heldt J.P., Spengler N.M., Nicolay L.I., et al. Effect of low dose radiation computerized tomography protocols on distal ureteral calculus detection. J Urol. 2009; №182 (6):2762-7.
  64. Niemann T., Kollmann T., Bongartz G. Diagnostic performance of low-dose CT for the detection of urolithiasis: a meta-analysis. AJR Am J Roentgenol. 2008; №191 (2):396-401.
  65. Xiang H., Chan M., Brown V., Huo Y.R., Chan L., et al. Systematic review and meta-analysis of the diagnostic accuracy of low-dose computed tomography of the kidneys, ureters and bladder for urolithiasis. J Med Imaging Radiat Oncol. 2017; №61 (5):582-590.
  66. Mancini J.G., Ferrandino M.N. The impact of new methods of imaging on radiation dosage delivered to patients. Curr Opin Urol. 2010; №20 (2):163-8.
  67. McCollough C.H., Primak A.N., Braun N., Kofler J., Yu L., Christner J. Strategies for reducing radiation dose in CT. Radiol Clin North Am. 2009; №47 (1):27-40.
  68. Mulkens T.H., Daineffe S., De Wijngaert R., Bellinck P., Leonard A., et al. Urinary stone disease: comparison of standard-dose and low-dose with 4D MDCT tube current modulation. AJR Am J Roentgenol. 2007; №188 (2):553-62.
  69. Kim B.S., Hwang I.K., Choi Y.W., Namkung S., Kim H.C., et al. Low-dose and standard-dose unenhanced helical computed tomography for the assessment of acute renal colic: prospective comparative study. Acta Radiol. 2005; №46 (7):756-63.
  70. Kawashima A., Sandler C.M., Ernst R.D., Tamm E.P., Goldman S.M., et al. CT evaluation of renovascular disease. Radiographics. 2000; №20 (5):1321-40.
  71. Agochukwu N., Huber S., Spektor M., Goehler A., Israel G.M. Differentiating Renal Neoplasms From Simple Cysts on Contrast-Enhanced CT on the Basis of Attenuation and Homogeneity. AJR Am J Roentgenol. 2017; №208 (4):801-804.
  72. Schiappacasse G., Aguirre J., Soffia P., Silva C.S., Zilleruelo N. CT findings of the main pathological conditions associated with horseshoe kidneys. Br J Radiol. 2015; №88 (1045):20140456.
  73. Rao P.N. Imaging for kidney stones. World J Urol. 2004; №22 (5):323-7.
  74. Ray A.A., Ghiculete D., Pace K.T., Honey R.J. Limitations to ultrasound in the detection and measurement of urinary tract calculi. Urology. 2010; №76 (2):295-300.
  75. Chua M.E., Gomez O.R., Sapno L.D., Lim S.L., Morales M.L.Jr. Use of computed tomography scout film and Hounsfield unit of computed tomography scan in predicting the radio-opacity of urinary calculi in plain kidney, ureter and bladder radiographs. Urol Ann. 2014; №6 (3):218-23.
  76. Jackman S.V., Potter S.R., Regan F., Jarrett T.W. Plain abdominal x-ray versus computerized tomography screening: sensitivity for stone localization after nonenhanced spiral computerized tomography. J Urol. 2000; №164 (2):308-10.
  77. Heidenreich A., Desgrandschamps F., Terrier F. Modern approach of diagnosis and management of acute flank pain: review of all imaging modalities. Eur Urol. 2002; №41 (4):351-62.
  78. Mutgi A., Williams J.W., Nettleman M. Renal colic. Utility of the plain abdominal roentgenogram. Arch Intern Med. 1991; №151 (8):1589-92.
  79. Kennish S.J., Bhatnagar P., Wah T.M., Bush S., Irving H.C. Is the KUB radiograph redundant for investigating acute ureteric colic in the non-contrast enhanced computed tomography era? Clin Radiol. 2008; №63 (10):1131-5.
  80. Rob S, Bryant T, Wilson I, Somani BK. Ultra-low-dose, low-dose, and standard-dose CT of the kidney, ureters, and bladder: is there a difference? Results from a systematic review of the literature. Clinical Radiology. 2017; №72(1):11-15.
  81. Cheng RZ, Shkolyar E, Chang TC, Spradling K, Ganesan C, Song Sh, Pao AC., Leppert JT, Elliott CS, To"o K, Conti SL. Ultra-Low-Dose CT: An Effective Follow-Up Imaging Modality for Ureterolithiasis. Journal of Endourology 2020; №34(2): 139-144.
  82. Yuan C, Jian Z, Jin X, Ma Y, Li H, Wang K. Efficacy and Safety of External Physical Vibration Lithecbole After Extracorporeal Shock Wave Lithotripsy or Retrograde Intrarenal Surgery for Urinary Stone: A Systematic Review and Meta-analysis. J Endourol. 2021; №35(5):712-720.
  83. Turgut H. Evaluation of the efficacy of sexual intercourse on distal ureteral stones in women: a prospective, randomized, controlled study. Int Urol Nephrol. 2021; №53(3):409-413.
  84. Bayraktar Z, Albayrak S. Sexual intercourse as a new option in the medical expulsive therapy of distal ureteral stones in males: a prospective, randomized, controlled study. Int Urol Nephrol. 2017; №49(11):1941-1946.
  85. Xu B, Yan H, Zhang X, Cui Y. Meta-analysis of the efficacy of sexual intercourse for distal ureteric stones. J Int Med Res. 2019; №47(2):497-504.
  86. Fernandes VS, Hernández M. The Role of Nitric Oxide and Hydrogen Sulfide in Urinary Tract Function. Basic Clin Pharmacol Toxicol. 2016;119 Suppl 3:34-41.
  87. Hedlund P. Nitric oxide/cGMP-mediated effects in the outflow region of the lower urinary tract--is there a basis for pharmacological targeting of cGMP? World J Urol. 2005; №23(6):362-7.
  88. Mastrangelo D, Baertschi AJ, Roatti A, Amherdt M, Iselin CE. Nitric oxide production within rat urothelial cells. J Urol. 2003; №170(4 Pt 1):1409-14.
  89. Campschroer T., Zhu X., Vernooij R.W., Lock MT.WT. Alpha-blockers as medical expulsive therapy for ureteral stones // Cochrane Database of Systematic Reviews. 2018; (4): CD008509.
  90. Coll DM, Varanelli MJ, Smith RC. Relationship of spontaneous passage of ureteral calculi to stone size and location as revealed by unenhanced helical CT. Am. J. Roentgenol. 2002; №178, (1): 101–103.
  91. Hübner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur. Urol. 1993; №24(2): 172–176.
  92. Jendeberg J, Geijer H, Alshamari M, Cierzniak B, Lidén M. Size matters: The width and location of a ureteral stone accurately predict the chance of spontaneous passage. Eur. Radiol. 2017; №27(11): 4775–4785.
  93. Furyk J. S., Chu K., Banks C., Greenslade J., Keijzers G., Thom O., Narula R. Distal Ureteric Stones and Tamsulosin: A Double-Blind, Placebo-Controlled, Randomized, Multicenter Trial. Annals of Emergency Medicine. 2016; №67(1):86–95.
  94. Lucarelli G., Ditonno P., Bettocchi C., Grandaliano G., Gesualdo L., et al. Delayed relief of ureteral obstruction is implicated in the long-term development of renal damage and arterial hypertension in patients with unilateral ureteral injury. J Urol. 2013; №189 (3):960-5.
  95. Liatsikos E.N., Katsakiori P.F., Assimakopoulos K., Voudoukis T., Kallidonis P., et al. Doxazosin for the management of distal-ureteral stones. J Endourol. 2007; №21 (5):538-41.
  96. Hollingsworth J.M., Rogers M.A., Kaufman S.R., Bradford T.J., Saint S., et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet. 2006; №368 (9542):1171-9.
  97. Lojanapiwat B., Kochakarn W., Suparatchatpan N., Lertwuttichaikul K. Effectiveness of low-dose and standard-dose tamsulosin in the treatment of distal ureteric stones: a randomized controlled study. J Int Med Res. 2008; №36 (3):529-36.
  98. Wang C.J., Huang S.W., Chang C.H. Efficacy of an alpha1 blocker in expulsive therapy of lower ureteral stones. J Endourol. 2008; №22 (1): с.41-46.
  99. Kaneko T., Matsushima H., Morimoto H., Tsuzaka Y., Homma Y. Efficacy of low dose tamsulosin in medical expulsive therapy for ureteral stones in Japanese male patients: a randomized controlled study. Int J Urol. 2010; №17 (5):462-5.
  100. Yilmaz E., Batislam E., Basar M.M., Tuglu D., Ferhat M., et al. The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol. 2005; №173 (6): с.2010-2.
  101. Zehri A.A., Ather M.H., Abbas F., Biyabani S.R. Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric stones in a randomized clinical trial. Urology. 2010; №75 (6): 1285-8.
  102. Mohseni M.G., Hosseini S.R., Alizadeh F. Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi Med J. 2006; №27 (6):838-40.
  103. Agrawal M., Gupta M., Gupta A., Agrawal A., Sarkari A., et al. Prospective randomized trial comparing efficacy of alfuzosin and tamsulosin in management of lower ureteral stones. Urology. 2009; №73 (4):706–709.
  104. Pedro R.N., Hinck B., Hendlin K., Feia K., Canales B.K., et al. Alfuzosin stone expulsion therapy for distal ureteral calculi: a double-blind, placebo controlled study. J Urol. 2008; №179 (6):2244-7.
  105. Ahmed A.F., Al-Sayed A.Y. Tamsulosin versus Alfuzosin in the Treatment of Patients with Distal Ureteral Stones: Prospective, Randomized, Comparative Study. Korean J Urol. 2010; №51 (3):193-7.
  106. Chau L.H., Tai D.C., Fung B.T., Li J.C., Fan C.W., et al. Medical expulsive therapy using alfuzosin for patient presenting with ureteral stone less than 10mm: a prospective randomized controlled trial. Int J Urol. 2011; №18 (7):510-4.
  107. Tsuzaka Y., Matsushima H., Kaneko T., Yamaguchi T., Homma Y. Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients. Int J Urol. 2011; №18 (11): с.792-5.
  108. Itoh Y., Okada A. Yasui T. Hamamoto S. Hirose M. et al. Efficacy of selective α1A adrenoceptor antagonist silodosin in the medical expulsive therapy for ureteral stones. Int J Urol. 2011; №18 (9):672-4.
  109. Sairam K. Should we SUSPEND MET? Not really. Cent European J Urol. 2016; №69 (2):183.
  110. Rodman J.S., Williams J.J., Peterson C.M. Dissolution of uric acid calculi. J Urol. 1984; №131 (6):1039-44.
  111. Becker G. The CARI guidelines. Kidney stones: uric acid stones. Nephrology (Carlton). 2007; №12 (1):21-5.
  112. Hernandez Y, Costa-Bauza A, Calvó P, Benejam J, Sanchis P, Grases F. Comparison of Two Dietary Supplements for Treatment of Uric Acid Renal Lithiasis: Citrate vs. Citrate + Theobromine. Nutrients. 2020; №12(7):2012.
  113. Bultitude M., Rees J. Management of renal colic. BMJ. 2012; 345:e5499.
  114. El-Gamal O., El-Bendary M., Ragab M., Rasheed M. Role of combined use of potassium citrate and tamsulosin in the management of uric acid distal ureteral calculi. Urol Res. 2012; №40 (3):219-24.
  115. Davidov MI, Bunova NE. Comparative assessment of Canephron N and ciprofloxacin as monotherapy of acute uncomplicated cystitis in women. Urologiia. 2018; № (4):24-32. Russian.
  116. Демидко Ю.Л., Руденко В.И., Григорян В.А., Еникеев М.Э., Алленов С.Н., Каситериди И.Г., и др. Клиническое значение применения препарата Канефрон® Н у больных МКБ после оперативного лечения. Урология. 2019. № 2: 15-20.
  117. Почерников Д.Г. Обзор опыта использования препарата КАНЕФРОН® Н в урологической практике с позиции доказательной медицины. Эффективная фармакотерапия. 2021; №17(25): 26-31.
  118. Гресь А.А., Вощула В.И., Рыбина И.Л., Шлома Л.П. Мочекаменная болезнь: опыт применения и эффективность Канефрона. Рецепт. 2006; № 3 (47): 83-87.
  119. Lokshin K.L. Comparative effectivenesss of standard antibiotic therapy and Canephron N asymptomatic bacteriuria in pregnant women. Urologiia. 2018. № 3: 54-57.
  120. Aliaev Iu.G., Rudenko V.I., Saenko V.S. et al. Herbal preparation Canephron N in the treatment of patients with urolithiasis. Urologiia. 2012; № 6(22): 24-25.
  121. Просянников М.Ю., Золотухин О.В., Мадыкин Ю.Ю., Константинова О.В., Войтко Д.А., Анохин Н.В., Сивков А.В. Влияние фитопрепарата на основе комбинации природных терпенов, витамина е и эфирного масла на отхождение фрагментов камней после дистанционной нефролитотрипсии Урология. 2020;4:45-49.
  122. Просянников М.Ю., Золотухин О.В., Мадыкин Ю.Ю., Константинова О.В., Войтко Д.А., Анохин Н.В., и др. литокинетическая терапия после ДУВЛ: возможности натуральных терпенов в комплексе с витамином Е. Экспериментальная и клиническая урология. 2021; 14(1): 87-93.
  123. Медведев В.Л., Михайлов И.В., Розенкранц А.М., Ефремов М.Е., Муратов К.У., Буданов А.А. применение растительной добавки на основе терпенов ренотинекс в комплексной терапии пациентов с мочекаменной болезнью. Урология. 2020; № 1: 32-38.
  124. Котов С.В., Неменов А.А., Боева И.Д. Результаты применения растительного комплекса Ренотинекс у больных мочекаменной болезнью в раннем послеоперационном периоде. Экспериментальная и клиническая урология. 2020; № 4: 35-41.
  125. Круглов В.А., Асфандияров Ф.Р., Выборнов С.В., Сеидов К.С., Калашников Е.С., Ляшенко В.В. Литокинетическая терапия пациентов с мочекаменной болезнью. Экспериментальная и клиническая урология. 2020; № 2: 105-111.
  126. Неймарк А., Неймарк Б., Гаткин М., Ноздрачев Н., Торбик Д., Левин В., и др. Многокомпонентный комплекс нефрадоз в лечении пациентов с мочекаменной болезнью. Врач. 2015; №8: 27-31.
  127. Камалов А.А., Абоян И.А., Деревянко Т.И., Еркович А.А., Журавлев В.Н., Комяков Б.К., и др. Применение нефрадоза у пациентов с мочекаменной болезнью, перенесших дистанционную ударно-волновую литотрипсию. Урология. 2014; № 3: 13-17.
  128. Мартов А.Г., Ергаков Д.В. реабилитация пациентов после выполнения современных эндоурологических операций по поводу мочекаменной болезни. Урология. 2018; № 4: 49-55.
  129. Мартов А.Г., Круглов В.А., Асфандияров Ф.Р., Выборнов С.В., Ольховская С.А., Круглова Е.Ю. Фитотерапия пациентов с резидуальными конкрементами верхних мочевых путей после литотрипсии. Экспериментальная и клиническая урология. 2019; № 1: 82-89.
  130. Капсаргин Ф.П., Саенко В.С., Трояков В.М., Буторова И.В., Голубева Д.Г., Зуева Л.Ф., и др. Роль растительных препаратов в литокинетической терапии и метафилактике мочекаменной болезни клиническое исследование. Экспериментальная и клиническая урология. 2021; № 14(2): 92-99.
  131. Ткачук В.Н., Аль-Шукри А.С., Ткачук И.Н. Эффективность применения пролита больными с камнем мочеточника .Урология. 2013; № 5: 35-36.
  132. Дутов В.В., Румянцев А.А., Попов Д.В., Подойницын А.А., Буймистр С.Ю., Сидо Ж., и др. Медикаментозная экспульсивная терапия камней мочеточника. Уральский медицинский журнал. 2018; № 7 (162): 127-131.
  133. Гапоненко А.Д., Доста Н.И., Ниткин Д.М., Вощула В.И., Лелюк В.Ю., Ненартович В.С. Возможности применения препарата Уролесан® в лечении заболеваний мочевой системы. Медицинские новости. 2012; № 4: 61-64.
  134. Наджимитдинов Я.С. эффективность применения препарата уролесан после экстракорпоральной ударно-волновой литотрипсии у детей. Урологические ведомости. 2019; №9: 62-63.
  135. Капсаргин Ф.П., Зуева Л.Ф., Козлякова В.Н. Опыт применения растительного комплекса уриклар в метафилактике нефролитиаза. Эффективная фармакотерапия. 2019; № 15(16): 12-19.
  136. Шестаев А.Ю., Протощак В.В., Паронников М.В., Киселев А.О. Комбинированный (цитратный и растительный) препарат уриклар в дистанционной литотрипсии и метафилактике мочекаменной болезни. Урологические ведомости. 2018; № 8(1): 19-25.
  137. Preminger G.M., Tiselius H.G., Assimos D.G., Alken P., Buck A.C., et al. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007; №52 (6):1610-31.
  138. Skolarikos A., Laguna M.P., Alivizatos G., Kural A.R., de la Rosette J.J. The role for active monitoring in urinary stones: a systematic review. J Endourol. 2010; №24 (6):923-30.
  139. Skolarikos A., Mitsogiannis H., Deliveliotis C. Indications, prediction of success and methods to improve outcome of shock wave lithotripsy of renal and upper ureteral calculi. Arch Ital Urol Androl. 2010; №82 (1):56-63.
  140. Pearle M.S., Pierce H.L., Miller G.L., Summa J.A., Mutz J.M., et al. Optimal method of urgent decompression of the collecting system for obstruction and infection due to ureteral calculi. J Urol. 1998; №160 (4):1260-4.
  141. Mokhmalji H., Braun P.M., Martinez Portillo F.J., Siegsmund M., Alken P., et al. Percutaneous nephrostomy versus ureteral stents for diversion of hydronephrosis caused by stones: a prospective, randomized clinical trial. J Urol. 2001; №165 (4):1088-92.
  142. Yoshimura K., Utsunomiya N., Ichioka K., Ueda N., Matsui Y., et al. Emergency drainage for urosepsis associated with upper urinary tract calculi. J Urol. 2005; №173 (2):458-62.
  143. Ramsey S., Robertson A., Ablett M.J., Meddings R.N., Hollins G.W., et al. Evidence-based drainage of infected hydronephrosis secondary to ureteric calculi. J Endourol. 2010; №24 (2):185-9.
  144. Иванов В.Ю., Малхасян В.А., Семенякин И.В., Гаджиев Н.К., Тедеев А.В., и др. Выбор оптимального метода дренирования верхних мочевых путей при остром обструктивном пиелонефрите. Экспериментальная и клиническая урология. 2017; №1:58-67.
  145. Marien T., Mass A.Y., Shah O. Antimicrobial resistance patterns in cases of obstructive pyelonephritis secondary to stones. Urology. 2015; №85 (1):64-8.
  146. Mariappan P., Loong C.W. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. 2004; №171 (6):2142-5.
  147. Naboka Y.L., Gudima I.A., Mitusova E.V., Bedzhanyan S.K., Morgun P.P. Antimicrobial resistance of uropathogens in patients with acute obstructive pyelonephritis. Urologiia. 2017; 4:27-31.
  148. Pasiechnikov S., Buchok O., Sheremeta R., Banyra O. Empirical treatment in patients with acute obstructive pyelonephritis. Infect Disord Drug Targets. 2015; №15 (3):163-70.
  149. Vahlensieck W., Friess D., Fabry W., Waidelich R., Bschleipfer T. Long-term results after acute therapy of obstructive pyelonephritis. Urol Int. 2015; №94 (4):436-41.
  150. Wagenlehner F.M., Tandogdu Z., Bjerklund Johansen T.E. An update on classification and management of urosepsis. Curr Opin Urol. 2017; №27 (2):133-137.
  151. Wagenlehner F.M., Lichtenstern C., Rolfes C., Mayer K., Uhle F., et al. Diagnosis and management for urosepsis. Int J Urol. 2013; №20 (10):963-70.
  152. Wagenlehner F.M., Pilatz A., Weidner W. Urosepsis – from the view of the urologist. Int J Antimicrob Agents. 2011; №38:51-57.
  153. Dellinger R.P., Levy M.M., Carlet J.M. et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008; №36 (1):296-327.
  154. Малхасян В.А., Иванов В.Ю., Ходырева Л.А., Дударева А.А., Куприянов Ю.А., и др. Анализ оказания специализированной медицинской помощи пациентам с острым обструктивным пиелонефритом в урологических стационарах г. Москвы. Экспериментальная и клиническая урология. 2016; №4:26-30.
  155. Cui X., Ji F., Yan H., Ou T.W., Jia C.S., et al. Comparison between extracorporeal shock wave lithotripsy and ureteroscopic lithotripsy for treating large proximal ureteral stones: a meta-analysis. Urology. 2015; №85 (4):748-56.
  156. Drake T., Grivas N., Dabestani S., Knoll T., Lam T., et al. What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review. Eur Urol. 2017; №72 (5):772-786.
  157. Aboumarzouk O.M., Kata S.G., Keeley F.X., McClinton S., Nabi G. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012; №16 (5):CD006029.
  158. Xu Y., Lu Y., Li J., Luo S., Liu Y., et al. A meta-analysis of the efficacy of ureteroscopic lithotripsy and extracorporeal shock wave lithotripsy on ureteral calculi. Acta Cir Bras. 2014; №29 (5):346-52.
  159. Ishii H., Couzins M., Aboumarzouk O., Biyani C.S., Somani B.K. Outcomes of Systematic Review of Ureteroscopy for Stone Disease in the Obese and Morbidly Obese Population. J Endourol. 2016; №30 (2):135-45.
  160. Delakas D., Karyotis I., Daskalopoulos G., Lianos E., Mavromanolakis E. Independent predictors of failure of shockwave lithotripsy for ureteral stones employing a second-generation lithotripter. J Endourol. 2003; №17 (4):201-5.
  161. Yang C., Li S., Cui Y. Comparison of YAG Laser Lithotripsy and Extracorporeal Shock Wave Lithotripsy in Treatment of Ureteral Calculi: A Meta-Analysis. Urol Int. 2017; №98 (4):373-381.
  162. Ouzaid I., Al-qahtani S., Dominique S., Hupertan V., Fernandez P., et al. A 970 Hounsfield units (HU) threshold of kidney stone density on non-contrast computed tomography (NCCT) improves patients" selection for extracorporeal shockwave lithotripsy (ESWL): evidence from a prospective study. BJU Int. 2012; №110 (11):438-42.
  163. Shinde S., Al Balushi Y., Hossny M., Jose S., Al Busaidy S. Factors Affecting the Outcome of Extracorporeal Shockwave Lithotripsy in Urinary Stone Treatment. Oman Med J. 2018; №33 (3):209-217.
  164. Razvi H., Fuller A., Nott L., Méndez-Probst C.E., Leistner R., et al. Risk factors for perinephric hematoma formation after shockwave lithotripsy: a matched case-control analysis. J Endourol. 2012; №26 (11):1478-82.
  165. Schnabel M.J., Gierth M., Bründl J., Chaussy C.G., Burger M., et al. Antiplatelet and anticoagulative medication during shockwave lithotripsy. J Endourol. 2014; №28 (9):1034-9.
  166. Elkoushy M.A., Violette P.D., Andonian S. Ureteroscopy in patients with coagulopathies is associated with lower stone-free rate and increased risk of clinically significant hematuria. Int Braz J Urol. 2012; №38 (2):195-202.
  167. Watterson J.D., Girvan A.R., Cook A.J., Beiko D.T., Nott L., et al. Safety and efficacy of holmium: YAG laser lithotripsy in patients with bleeding diatheses. J Urol. 2002; №168 (2):442-5.
  168. Aboumarzouk O.M., Somani B.K., Monga M. Flexible ureteroscopy and holmium:YAG laser lithotripsy for stone disease in patients with bleeding diathesis: a systematic review of the literature. Int Braz J Urol. 2012; №38(3):298-305.
  169. Toepfer N.J., Baylor K., Henry Y., Simmons J., Berger P.B. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy. Urology. 2013; №82 (4):773-9.
  170. Turna B, Stein R.J., Smaldone M.C., Santos B.R., Kefer J.C., et al. Safety and efficacy of flexible ureterorenoscopy and holmium:YAG lithotripsy for intrarenal stones in anticoagulated cases. J Urol. 2008; №179 (4):1415-9.
  171. Sharaf A., Amer T., Somani B.K., Aboumarzouk O.M. Ureteroscopy in Patients with Bleeding Diatheses, Anticoagulated, and on Anti-Platelet Agents: A Systematic Review and Meta-Analysis of the Literature. J Endourol. 2017; №31 (12):1217-1225.
  172. Wang Q., Guo J., Hu H., Lu Y., Zhang J., et al. Rigid ureteroscopic lithotripsy versus percutaneous nephrolithotomy for large proximal ureteral stones: A meta-analysis. PLoS One. 2017; №12 (2): e0171478.
  173. Wang Y., Zhong B., Yang X., Wang G., Hou P., et al. Comparison of the efficacy and safety of URSL, RPLU, and MPCNL for treatment of large upper impacted ureteral stones: a randomized controlled trial. BMC Urol. 2017; №17 (1): 50.
  174. Wu T., Duan X., Chen S., Yang X., Tang T., Cui S. Ureteroscopic Lithotripsy versus Laparoscopic Ureterolithotomy or Percutaneous Nephrolithotomy in the Management of Large Proximal Ureteral Stones: A Systematic Review and Meta-Analysis. Urol Int. 2017; №99 (3):308-319.
  175. Topaloglu H., Karakoyunlu N., Sari S., Ozok H.U., Sagnak L., et al. A comparison of antegrade percutaneous and laparoscopic approaches in the treatment of proximal ureteral stones. Biomed Res Int. 2014; 2014:691946.
  176. Prakash J., Singh V., Kumar M., Kumar M., Sinha R.J., et al. Retroperitoneoscopic versus open mini-incision ureterolithotomy for upper- and mid-ureteric stones: a prospective randomized study. Urolithiasis. 2014; №42 (2):133-9.
  177. Skolarikos A., Papatsoris A.G., Albanis S., Assimos D. Laparoscopic urinary stone surgery: an updated evidence-based review. Urol Res. 2010; №38 (5):337-44.
  178. Kumar A., Vasudeva P., Nanda B., Kumar N., Jha S.K., Singh H. A Prospective Randomized Comparison Between Laparoscopic Ureterolithotomy and Semirigid Ureteroscopy for Upper Ureteral Stones >2 cm: A Single-Center Experience. J Endourol. 2015; №29 (11):1248-52.
  179. Torricelli F.C., Monga M., Marchini G.S., Srougi M., Nahas W.C., Mazzucchi E. Semi-rigid ureteroscopic lithotripsy versus laparoscopic ureterolithotomy for large upper ureteral stones: a meta-analysis of randomized controlled trials. Int Braz J Urol. 2016; №42 (4):645-54.
  180. Kallidonis P., Ntasiotis P., Knoll T., Sarica K., Papatsoris A., et al. Minimally Invasive Surgical Ureterolithotomy Versus Ureteroscopic Lithotripsy for Large Ureteric Stones: A Systematic Review and Meta-analysis of the Literature. Eur Urol Focus. 2017; №3 (6):554-566.
  181. Sun X., Xia S., Lu J., Liu H., Han B., et al. Treatment of large impacted proximal ureteral stones: randomized comparison of percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy. J Endourol. 2008; №22 (5):913-7.
  182. Moufid K., Abbaka N., Touiti D., Adermouch L., Amine M., Lezrek M. Large impacted upper ureteral calculi: A comparative study between retrograde ureterolithotripsy and percutaneous antegrade ureterolithotripsy in the modified lateral position. Urol Ann. 2013; №5 (3):140-6.
  183. El-Nahas A.R., Eraky I., el-Assmy A.M., Shoma A.M., el-Kenawy M.R., Abdel-Latif M., et al. Percutaneous treatment of large upper tract stones after urinary diversion. Urology. 2006; №68 (3):500-4.
  184. El-Assmy A., El-Nahas A.R., Mohsen T., Eraky I., El-Kenawy M.R., Shaban A.A., et al. Extracorporeal shock wave lithotripsy of upper urinary tract calculi in patients with cystectomy and urinary diversion. Urology. 2005; №66 (3):510-3.
  185. Honeck P., Wendt-Nordahl G. Krombach P. Bach T. Häcker A. et al. Does open stone surgery still play a role in the treatment of urolithiasis? Data of a primary urolithiasis center. J Endourol. 2009; №23 (7):1209-12.
  186. Ohmori K., Matsuda T., Horii Y., Yoshida O. Effects of shock waves on the mouse fetus. J Urol. 1994; №151 (1):255-8.
  187. Smith D.P., Graham J.B., Prystowsky J.B., Dalkin B.L., Nemcek A.A. Jr. The effects of ultrasound-guided shock waves during early pregnancy in Sprague-Dawley rats. J Urol. 1992; №147 (1):231-4.
  188. Chaussy C.G., Fuchs G.J. Current state and future developments of noninvasive treatment of human urinary stones with extracorporeal shock wave lithotripsy. J Urol. 1989; 141:782–789.
  189. Mira Moreno A., Montoya Lirola M.D., García Tabar P.J., Galiano Baena J.F., Tenza Tenza J.A., et al. Incidence of infectious complications after extracorporeal shock wave lithotripsy in patients without associated risk factors. J Urol. 2014; №192 (5):1446-9.
  190. Honey R.J., Ordon M., Ghiculete D., Wiesenthal J.D., Kodama R., et al. A prospective study examining the incidence of bacteriuria and urinary tract infection after shock wave lithotripsy with targeted antibiotic prophylaxis. J Urol. 2013; №189 (6):2112-7.
  191. Lee SW, Yoon S, Do J, et al. The risk factors of recurrent febrile urinary tract infection within 1 year in urinary stone patients with acute obstructive pyelonephritis. Urogenital Tract Infect. 2017; 12:82-8.
  192. Westh H., Knudsen F., Hedengran A.M., Weischer M., Mogensen P., et al. Extracorporeal shock wave lithotripsy of kidney stones does not induce transient bacteremia. A prospective study. The Copenhagen Extracorporeal Shock Wave Lithotripsy Study Group. J Urol. 1990; №144 (1): 15-6.
  193. Duvdevani M., Lorber G., Gofrit O.N., Latke A., Katz R., et al. Fever after shockwave lithotripsy – risk factors and indications for prophylactic antimicrobial treatment. J Endourol. 2010; №24 (2):277-81.
  194. Streem S.B., Yost A. Extracorporeal shock wave lithotripsy in patients with bleeding diatheses. J Urol. 1990; №144 (6):1347-8.
  195. Klingler H.C., Kramer G., Lodde M., Dorfinger K., Hofbauer J., et al. Stone treatment and coagulopathy. Eur Urol. 2003; №43 (1):75-9.
  196. Ruiz H., Saltzman B. Aspirin-induced bilateral renal hemorrhage after extracorporeal shock wave lithotripsy therapy: implications and conclusions. J Urol. 1990; №143 (4):791-2.
  197. Knorr P.A., Woodside J.R. Large perirenal hematoma after extracorporeal shock-wave lithotripsy. Urology. 1990; №35 (2):151-3.
  198. Sare G.M., Lloyd F.R., Stower M.J. Life-threatening haemorrhage after extracorporeal shockwave lithotripsy in a patient taking clopidogrel. BJU Int. 2002; №90 (4):469.
  199. Alsaikhan B., Andonian S. Shock wave lithotripsy in patients requiring anticoagulation or antiplatelet agents. Can Urol Assoc J. 2011; 5:53–57.
  200. Rechenmacher S.J., Fang J.C. Bridging Anticoagulation: Primum Non Nocere. J Am Coll Cardiol. 2015; №66 (12):1392-403.
  201. Altay B., Erkurt B., Albayrak S. A review study to evaluate holmium:YAG laser lithotripsy with flexible ureteroscopy in patients on ongoing oral anticoagulant therapy. Lasers Med Sci. 2017 №32 (7):1615-1619.
  202. Carey S.W., Streem S.B. Extracorporeal shock wave lithotripsy for patients with calcified ipsilateral renal arterial or abdominal aortic aneurysms. J Urol. 1992; №148 (1):18-20.
  203. Vasavada S.P., Streem S.B., Kottke-Marchant K., Novick A.C. Pathological effects of extracorporeally generated shock waves on calcified aortic aneurysm tissue. J Urol. 1994; №152 (1):45-8.
  204. Tse G.H., Qazi H.A., Halsall A.K., Nalagatla S.R. Shockwave lithotripsy: arterial aneurysms and vascular complications. J Endourol. 2011; №25 (3):403-11.
  205. Wang H., Man L., Li G., Huang G., Liu N., et al. Meta-Analysis of Stenting versus Non-Stenting for the Treatment of Ureteral Stones. PLoS One. 2017; №12 (1):0167670.   
  206. Shen P., Jiang M., Yang J., Li X., Li Y., et al. Use of ureteral stent in extracorporeal shock wave lithotripsy for upper urinary calculi: a systematic review and meta-analysis. J Urol. 2011; №186 (4):1328-35.
  207. Ghoneim I.A., El-Ghoneimy M.N., El-Naggar A.E., Hammoud K.M., El-Gammal M.Y., et al. Extracorporeal shock wave lithotripsy in impacted upper ureteral stones: a prospective randomized comparison between stented and non-stented techniques. Urology. 2010; №75 (1):45-50.
  208. Lu Y., Tianyong F., Ping H., Qiang W. Antibiotic Prophylaxis for Shock Wave Lithotripsy in Patients with Sterile Urine Before Treatment May be Unnecessary: A Systematic Review and Meta-Analysis. J Urol. 2012; №14: S0022-5347(12)04900-2.
  209. Bootsma A.M., Laguna Pes M.P., Geerlings S.E., Goossens A. Antibiotic prophylaxis in urologic procedures: a systematic review. Eur Urol. 2008; №54 (6):1270-86.
  210. Alexander C.E., Gowland S., Cadwallader J., et al. Routine antibiotic prophylaxis is not required for patients undergoing shockwave lithotripsy: outcomes from a national shockwave lithotripsy database in New Zealand. J Endourol. 2016; 30:1233–8.
  211. Wollin D.A., Joyce A.D., Gupta M., Wong MY.C., Laguna P., et al. Antibiotic use and the prevention and management of infectious complications in stone disease. World J Urol. 2017; №35 (9):1369-1379.
  212. Li K., Lin T., Zhang C., Fan X., Xu K., et al. Optimal frequency of shock wave lithotripsy in urolithiasis treatment: a systematic review and meta-analysis of randomized controlled trials. J Urol. 2013; №190 (4):1260-7.
  213. Semins M.J., Trock B.J., Matlaga B.R. The effect of shock wave rate on the outcome of shock wave lithotripsy: a meta-analysis. J Urol. 2008; №179 (1):194-7.
  214. Connors B.A., Evan A.P., Blomgren P.M., Handa R.K., Willis L.R., et al. Extracorporeal shock wave lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJU Int. 2009; №104 (7):1004-8.
  215. Connors B.A., Evan A.P., Blomgren P.M., Handa R.K., Willis L.R., et al. Effect of initial shock wave voltage on shock wave lithotripsy-induced lesion size during step-wise voltage ramping. BJU Int. 2009; №103 (1):104-7.
  216. Handa R.K., McAteer J.A., Connors B.A., Liu Z., Lingeman J.E., et al. Optimising an escalating shockwave amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy. BJU Int. 2012; №110 (11):1041-7.
  217. Skuginna V., Nguyen D.P., Seiler R., Kiss B., Thalmann G.N., et al. Does Stepwise Voltage Ramping Protect the Kidney from Injury During Extracorporeal Shockwave Lithotripsy? Results of a Prospective Randomized Trial. Eur Urol. 2016; №69 (2): с.267-73.
  218. Maloney M.E., Marguet C.G., Zhou Y., Kang D.E., Sung J.C., et al. Progressive Increase of Lithotripter Output Produces Better in-Vivo Stone Comminution. J Endourol. 2006; №20 (9): 603–606.
  219. Demirci D., Sofikerim M., Yalçin E., Ekmekçioğlu O., Gülmez I., et al. Comparison of conventional and step-wise shockwave lithotripsy in management of urinary calculi. J Endourol. 2007; №21 (12):1407-10.
  220. Pishchalnikov Y.A., Neucks J.S., VonDerHaar R.J., Pishchalnikova I.V., Williams J.C. Jr, et al. Air pockets trapped during routine coupling in dry head lithotripsy can significantly decrease the delivery of shock wave energy. J Urol. 2006; №176 (6):2706-10.
  221. Jain A., Shah T.K. Effect of air bubbles in the coupling medium on efficacy of extracorporeal shock wave lithotripsy. Eur Urol. 2007; №51 (6):1680-6.
  222. Wendt-Nordahl G., Mut T., Krombach P., Michel M.S., Knoll T. Do new generation flexible ureterorenoscopes offer a higher treatment success than their predecessors? Urol Res. 2011; №39 (3): с.185-188.
  223. Deng T., Liu B., Duan X., Cai C., Zhao Z., et al. Antibiotic prophylaxis in ureteroscopic lithotripsy: a systematic review and meta-analysis of comparative studies. BJU Int. 2018; №122 (1):29-39.
  224. Lo C.W., Yang S.S., Hsieh C.H., Chang S.J. Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis. Surg Infect (Larchmt). 2015; №16 (4):415-20.
  225. Martov A., Gravas S., Etemadian M., Unsal A., Barusso G., et al. Postoperative infection rates in patients with a negative baseline urine culture undergoing ureteroscopic stone removal: a matched case-control analysis on antibiotic prophylaxis from the CROES URS global study. J Endourol. 2015; №29 (2):171-80.
  226. Chew B.H., Flannigan R., Kurtz M., Gershman B., Arsovska O., et al. A Single Dose of Intraoperative Antibiotics Is Sufficient to Prevent Urinary Tract Infection During Ureteroscopy. J Endourol. 2016; №30 (1):63-8.
  227. Chi-Wen Lo, Stephen Shei-Dei Yang, Cheng-Hsing Hsieh, Shang-Jen Chang. Effectiveness of Prophylactic Antibiotics against Post-Ureteroscopic Lithotripsy Infections: Systematic Review and Meta-Analysis. PMID: 26207401
  228. Baseskioglu B. The Prevalence of Urinary Tract Infection Following Flexible Ureterenoscopy and the Associated Risk Factors. Urol J. 2019 Oct 21;16(5):439-442.
  229. Li T, Sun XZ, Lai DH, Li X, He YZ. Fever and systemic inflammatory response syndrome after retrograde intrarenal surgery: Risk factors and predictive model. Kaohsiung J Med Sci. 2018; №34(7):400-408.
  230. Zhong W, Leto G, Wang L, Zeng G. Systemic inflammatory response syndrome after flexible ureteroscopic lithotripsy: a study of risk factors. J Endourol. 2015; №29(1): 25-8.
  231. Baboudjian M., Gondran-Tellier B., Abdallah R., Sichez P.C., Akiki A., Gaillet S., et al. Predictive risk factors of urinary tract infection following flexible ureteroscopy despite preoperative precautions to avoid infectious complications. World J Urol. 2020; №38(5): 1253-1259.
  232. Demir D.O., Doluoglu O.G., Yildiz Y., Bozkurt S., Ayyildiz A., Demirbas A. Risk Factors for Infectious Complications in Patients Undergoing Retrograde Intrarenal Surgery. J Coll Physicians Surg Pak. 2019; №29(6):558-562.
  233. Castellani D., Teoh J.Y., Pavia M.P., Pretore E., Dell"Atti L., Galosi AB., et al. Assessing the Optimal Urine Culture for Predicting Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy and Retrograde Intrarenal Surgery: Results from a Systematic Review and Meta-Analysis. J Endourol. 2022; №36(2):158-168.
  234. Wang F., Hong Y., Yang Z., Ye L. Comparison of retrograde intrarenal surgery and standard percutaneous nephrolithotomy for management of stones at ureteropelvic junction with high-grade hydronephrosis. Sci Rep. 2021; №11(1):14050.
  235. Dybowski B., Bres-Niewada E., Rzeszutko M., Tkaczyk A., Woźniak B., Wójcik M., et al. Risk factors for infectious complications after retrograde intrarenal surgery - a systematic review and narrative synthesis. Cent European J Urol. 2021; 74(3):437-445.
  236. Zhang H., Jiang T.., Gao R, Chen Q., Chen W., Liu C., et al. Risk factors of infectious complications after retrograde intrarenal surgery: a retrospective clinical analysis. J Int Med Res. 2020; №48(9)
  237. Corrales M., Sierra A, Doizi S., Traxer O. Risk of Sepsis in Retrograde Intrarenal Surgery: A Systematic Review of the Literature. Eur Urol Open Sci. 2022; №44:84-91..
  238. Kim D.S., Yoo K.H., Jeon S.H., Lee S.H. Risk factors of febrile urinary tract infections following retrograde intrarenal surgery for renal stones. Medicine (Baltimore). 2021; №100(13):25182.
  239. Dickstein R.J., Kreshover J.E., Babayan R.K., Wang D.S. Is a safety wire necessary during routine flexible ureteroscopy? J Endourol. 2010; №24 (10):1589-92.
  240. Eandi J.A., Hu B., Low R.K. Evaluation of the impact and need for use of a safety guidewire during ureteroscopy. J Endourol. 2008; №22 (8):1653-8.
  241. Ulvik Ø., Rennesund K., Gjengstø P., Wentzel-Larsen T., Ulvik N.M. Ureteroscopy with and without safety guide wire: should the safety wire still be mandatory? J Endourol. 2013; №27 (10): 1197-202.
  242. Molina W.R. Jr, Pessoa R.R., Silva R.D., Gustafson D., Nogueira L., et al. Is a safety guidewire needed for retrograde ureteroscopy? Rev Assoc Med Bras (1992). 2017; №63 (8):717-721.
  243. Ulvik Ø., Wentzel-Larsen T., Ulvik N.M. A safety guidewire influences the pushing and pulling forces needed to move the ureteroscope in the ureter: a clinical randomized, crossover study. J Endourol. 2013; №27 (7):850-5.
  244. Tokas T., Herrmann T.R.W., Skolarikos A., Nagele U., Training and Research in Urological Surgery and Technology (T.R.U.S.T.) Group. Pressure matters: intrarenal pressures during normal and pathological conditions, and impact of increased values to renal physiology. World J Urol. 2019; №37 (1):125-131
  245. Omar M., Noble M., Sivalingam S., El Mahdy A., Gamal A. et al. Systemic Inflammatory Response Syndrome after Percutaneous Nephrolithotomy: A Randomized Single-Blind Clinical Trial Evaluating the Impact of Irrigation Pressure. J Urol. 2016; №196 (1):109-14.
  246. Ahmed M., Pedro R.N., Kieley S., Akornor J.W., Durfee W.K., et al. Systematic evaluation of ureteral occlusion devices: insertion, deployment, stone migration, and extraction. Urology. 2009; №73 (5):976-80.
  247. Leijte J.A., Oddens J.R., Lock T.M. Holmium laser lithotripsy for ureteral calculi: predictive factors for complications and success. J Endourol. 2008; №22 2):257-60.
  248. Pierre S., Preminger G.M. Holmium laser for stone management. World J Urol. 2007; №25 (3):235-9.
  249. Garg S., Mandal A.K., Singh S.K., Naveen A., Ravimohan M., et al. Ureteroscopic laser lithotripsy versus ballistic lithotripsy for treatment of ureteric stones: a prospective comparative study. Urol Int. 2009; №82 (3):341-5.
  250. Binbay M., Tepeler A., Singh A., Akman T., Tekinaslan E., et al. Evaluation of pneumatic versus holmium:YAG laser lithotripsy for impacted ureteral stones. Int Urol Nephrol. 2011; №43 (4):989-95.
  251. Martov A.G., Ergakov D.V., Guseinov M.A., Andronov A.S., Dutov S.V., et al. Initial experience in clinical application of thulium laser contact lithotripsy for transurethral treatment of urolithiasis. Urologiia. 2018; 1:112-120.
  252. Fried N.M., Irby P.B. Advances in laser technology and fibre-optic delivery systems in lithotripsy. Nat Rev Urol. 2018; №15 (9):563-573.
  253. Hardy L.A., Kennedy J.D., Wilson C.R., Irby P.B., Fried N.M. Analysis of thulium fiber laser induced bubble dynamics for ablation of kidney stones. J Biophotonics. 2017; №10 (10):1240-1249.
  254. Hardy L.A., Irby P.B., Fried N.M. Scanning electron microscopy of real and artificial kidney stones before and after Thulium fiber laser ablation in air and water. Proc. SPIE 10468, Therapeutics and Diagnostics in Urology. 2018; 104680G.
  255. Hardy L.A., Gonzalez D.A., Irby P.B., Fried N.M. Fragmentation and dusting of large kidney stones using compact, air-cooled, high peak power, 1940-nm, Thulium fiber laser. Therapeutics and Diagnostics in Urology. 2018; 104680O. 
  256. Yang Y., Tang Y., Bai Y., Wang X., Feng D., et al. Preoperative double-J stent placement can improve the stone-free rate for patients undergoing ureteroscopic lithotripsy: a systematic review and meta-analysis. Urolithiasis. 2018; №46 (5):493-499.
  257. Assimos D., Crisci A., Culkin D., Xue W., Roelofs A., et al. CROES URS Global Study Group. Preoperative JJ stent placement in ureteric and renal stone treatment: results from the Clinical Research Office of Endourological Society (CROES) ureteroscopy (URS) Global Study. BJU Int. 2016; №117 (4):648-54.
  258. Jessen J.P., Breda A., Brehmer M., Liatsikos E.N., Millan R.F., et al. International Collaboration in Endourology: Multicenter Evaluation of Prestenting for Ureterorenoscopy. J Endourol. 2016; №30 (3):268-73.
  259. Ambani S.N., Faerber G.J., Roberts W.W., Hollingsworth J.M., Wolf J.S. Jr. Ureteral stents for impassable ureteroscopy. J Endourol. 2013; №27 (5):549-53.
  260. Song T., Liao B., Zheng S., Wei Q. Meta-analysis of postoperatively stenting or not in patients underwent ureteroscopic lithotripsy. Urol Res. 2012; №40 (1):67-77.
  261. Pengfei S., Yutao L., Jie Y., Wuran W., Yi D., et al. The results of ureteral stenting after ureteroscopic lithotripsy for ureteral calculi: a systematic review and meta-analysis. J Urol. 2011; №186 (5):1904-9.
  262. Haleblian G., Kijvikai K., de la Rosette J., Preminger G. Ureteral stenting and urinary stone management: a systematic review. J Urol. 2008; №179 (2):424-30.
  263. Nabi G., Cook J., N"Dow J., McClinton S. Outcomes of stenting after uncomplicated ureteroscopy: systematic review and meta-analysis. BMJ. 2007; №334 (7593):572.
  264. Muslumanoglu A.Y., Fuglsig S., Frattini A., Labate G., Nadler R.B., et al. Risks and Benefits of Postoperative Double-J Stent Placement After Ureteroscopy: Results from the Clinical Research Office of Endourological Society Ureteroscopy Global Study. J Endourol. 2017; №31 (5):446-451.
  265. Zheng C., Xiong B., Wang H., Luo J., Zhang C., et al. Retrograde intrarenal surgery versus percutaneous nephrolithotomy for treatment of renal stones >2 cm: a meta-analysis. Urol Int. 2014; №93 (4): 417-24.
  266. Karakoyunlu N., Goktug G., Şener N.C., Zengin K., Nalbant .I, et al. A comparison of standard PCNL and staged retrograde FURS in pelvis stones over 2 cm in diameter: a prospective randomized study. Urolithiasis. 2015; №43 (3):283-7.
  267. Donaldson J.F., Lardas M., Scrimgeour D., Stewart F., MacLennan S., et al. Systematic review and meta-analysis of the clinical effectiveness of shock wave lithotripsy, retrograde intrarenal surgery, and percutaneous nephrolithotomy for lower-pole renal stones. Eur Urol. 2015;  №67 (4):612-6.
  268. Pearle M.S., Lingeman J.E., Leveillee R., Kuo R., Preminger G.M., et al. Prospective, randomized trial comparing shock wave lithotripsy and ureteroscopy for lower pole caliceal calculi 1 cm or less. J Urol. 2005; №173 (6):2005-9.
  269. Argyropoulos A.N., Tolley D.A. Evaluation of outcome following lithotripsy. Curr Opin Urol. 2010; №20 (2):154-8.
  270. De S., Autorino R., Kim F.J., Zargar H., Laydner H., et al. Percutaneous nephrolithotomy versus retrograde intrarenal surgery: a systematic review and meta-analysis. Eur Urol. 2015; №67 (1):125-137.
  271. Srisubat A., Potisat S., Lojanapiwat B., Setthawong V., Laopaiboon M. Extracorporeal shock wave lithotripsy (ESWL) versus percutaneous nephrolithotomy (PCNL) or retrograde intrarenal surgery (RIRS) for kidney stones. Cochrane Database Syst Rev. 2009; №7 (4):CD007044.
  272. Danuser H., Müller R., Descoeudres B., Dobry E., Studer U.E. Extracorporeal shock wave lithotripsy of lower calyx calculi: how much is treatment outcome influenced by the anatomy of the collecting system? Eur Urol. 2007; №52 (2):539-46.
  273. Preminger G.M. Management of lower pole renal calculi: shock wave lithotripsy versus percutaneous nephrolithotomy versus flexible ureteroscopy. Urol Res. 2006; №34 (2):108-11.
  274. Manikandan R., Gall Z., Gunendran T., Neilson D., Adeyoju A. Do anatomic factors pose a significant risk in the formation of lower pole stones? Urology. 2007; №69 (4):620-4.
  275. Zhang W., Zhou T., Wu T., Gao X., Peng Y., et al. Retrograde Intrarenal Surgery Versus Percutaneous Nephrolithotomy Versus Extracorporeal Shockwave Lithotripsy for Treatment of Lower Pole Renal Stones: A Meta-Analysis and Systematic Review. J Endourol. 2015; №29 (7): 745-59.
  276. Chai CA, Teoh YC, Tailly T, et al. Influence of pre-stenting on RIRS outcomes. Inferences from patients of the Global Multicentre Flexible Ureteroscopy Outcome Registry (FLEXOR). Minerva Urology and Nephrology. 2023; №75(4):493-500.
  277. Chang X. et al. Prestenting versus nonprestenting on the outcomes of flexible ureteroscopy for large upper urinary stones: a systematic review and meta-analysis. Urologia Internationalis.  2021; № 105(7-8): 560-567.
  278. De la Rosette J., Denstedt J., Geavlete P., Keeley F., Matsuda T., et al. CROES URS Study Group. The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients. J Endourol. 2014; №28 (2):131-9.
  279. Butticè S., Sener T.E., Netsch C., Emiliani E., Pappalardo R., et al. A new single-use digital flexible ureteroscope. Cent European J Urol. 2016; №69 (3):302-305.
  280. Usawachintachit M., Isaacson D.S., Taguchi K., Tzou D.T., Hsi R.S., et al. Prospective Case-Control Study Comparing LithoVue, a Single-Use, Flexible Disposable Ureteroscope, with Flexible, Reusable Fiber-Optic Ureteroscopes. J Endourol. 2017; №31 (5):468-475.
  281. Doizi S., Kamphuis G., Giusti G., Andreassen K.H., Knoll T., et al. First clinical evaluation of a new single-use flexible ureteroscope (LithoVue™): a European prospective multicentric feasibility study. World J Urol. 2017; №35 (5):809-818.
  282. Гаджиев Н.К., Гаджиева А.Б., Моллаев Р.А., Горелов Д.С., Малхасян В.А., и др. Сравнительный обзор одноразовых гибких уретеронефроскопов. Экспериментальная и клиническая урология. 2018; №2: 36-43.
  283. Akar E, Knudsen B. Flexible ureteroscopy versus percutaneous nephrolithotomy as primary treatment for renal stones 2 cm or greater. Dovepress. 2013; №6:1-10.
  284. Hyams E.S., Munver R., Bird V.G., Uberoi J., Shah O. Flexible ureterorenoscopy and holmium laser lithotripsy for the management of renal stone burdens that measure 2 to 3 cm: a multi-institutional experience. J Endourol. 2010; №24 (10):1583-8.
  285. Hyams E.S., Shah O. Percutaneous nephrostolithotomy versus flexible ureteroscopy/holmium laser lithotripsy: cost and outcome analysis. J Urol. 2009; №182 (3):1012-7.
  286. Takazawa R., Kitayama S., Tsujii T. Successful outcome of flexible ureteroscopy with holmium laser lithotripsy for renal stones 2 cm or greater. Int J Urol. 2012; №19 (3):264-7.
  287. Ricchiuti D.J., Smaldone M.C., Jacobs B.L., Smaldone A.M., Jackman S.V., et al. Staged retrograde endoscopic lithotripsy as alternative to PCNL in select patients with large renal calculi. J Endourol. 2007; №21 (12):1421-4. doi: 10.1089/end.2007.9871.
  288. Aboumarzouk O.M., Monga M., Kata S.G., Traxer O., Somani B.K. Flexible ureteroscopy and laser lithotripsy for stones >2 cm: a systematic review and meta-analysis. J Endourol. 2012; №26 (10):1257-63.
  289. Geraghty R., Abourmarzouk O., Rai B., Biyani C.S., Rukin N.J., et al. Evidence for Ureterorenoscopy and Laser Fragmentation (URSL) for Large Renal Stones in the Modern Era. Curr Urol Rep. 2015; №16 (8):54.
  290. Yitgin B.Y., Yitgin E., Verep S., Gasimov K., Tefik T., Karakose A. Is Access Sheath Essential for Safety and Effective Retrograde Intrarenal Stone Surgery? Journal of the College of Physicians and Surgeons Pakistan. 2023; 33(12).
  291. Huang J., Zhao Z., AlSmadi J.K., Liang X., Zhong F., Zeng T., et al. Use of the ureteral access sheath during ureteroscopy: A systematic review and meta-analysis. PloS one. 2018; №13(2):
  292. Damar E., Senocak C., Ozbek R., Haberal H.B., Sadioglu F.E., Yordam M., Bozkurt O.F. Does ureteral access sheath affect the outcomes of retrograde intrarenal surgery: a prospective study. Minimally Invasive Therapy & Allied Technologies, 2022; 31(5): 777-781.
  293. Meier K., Hiller S., Dauw C., Hollingsworth J. Kim T., Ji Qi, et al. Understanding Ureteral Access Sheath Use Within a Statewide Collaborative and Its Effect on Surgical and Clinical Outcomes. Journal of Endourology. 2021; №35(9): 1340-1347.
  294. De Coninck V., Somani B., Sener E.T., Emiliani E., Corrales M., Juliebø-Jones P., et al. Ureteral Access Sheaths and Its Use in the Future: A Comprehensive Update Based on a Literature Review. Journal of Clinical Medicine. 2022; №11(17):5128.
  295. De Coninck V., Keller E.X., Rodríguez-Monsalve M., Audouin M., Doizi S., Traxer O. Systematic review of ureteral access sheaths: facts and myths. BJU Int. 2018; №122 (6):959-969.
  296. Breda A., Territo A., López-Martínez J.M. Benefits and risks of ureteral access sheaths for retrograde renal access. Curr Opin Urol. 2016; №26 (1):70-5.
  297. Traxer O., Wendt-Nordahl G., Sodha H., Rassweiler J., Meretyk S., et al. Differences in renal stone treatment and outcomes for patients treated either with or without the support of a ureteral access sheath: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study. World J Urol. 2015; №33 (12): с.2137-44.
  298. Yuan D., Liu Y., Rao H., Cheng T., Sun Z., et al. Supine Versus Prone Position in Percutaneous Nephrolithotomy for Kidney Calculi: A Meta-Analysis. J Endourol. 2016; №30 (7): 754-63.
  299. Falahatkar S., Mokhtari G., Teimoori M.. An Update on Supine Versus Prone Percutaneous Nephrolithotomy: A Meta-analysis. Urol J. 2016; №13 (5):2814-2822.
  300. Liu L., Zheng S., Xu Y., Wei Q. Systematic review and meta-analysis of percutaneous nephrolithotomy for patients in the supine versus prone position. J Endourol. 2010; №24 (12):1941-6.
  301. Wang K., Zhang P., Xu X., Fan M. Ultrasonographic versus Fluoroscopic Access for Percutaneous Nephrolithotomy: A Meta-Analysis. Urol Int. 2015; №95 (1): с.15-25.
  302. Liu Q., Zhou L., Cai X., Jin T., Wang K. Fluoroscopy versus ultrasound for image guidance during percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2017; №45 (5):481-487.
  303. Ganesamoni R., Sabnis R.B., Mishra S., Parekh N., Ganpule A., et al. Prospective randomized controlled trial comparing laser lithotripsy with pneumatic lithotripsy in miniperc for renal calculi. J Endourol. 2013; №27 (12):1444-9.
  304. Istanbulluoglu M.O., Ozturk B., Gonen M., Cicek T., Ozkardes H. Effectiveness of totally tubeless percutaneous nephrolithotomy in selected patients: a prospective randomized study. Int Urol Nephrol. 2009; №41 (3):541-5.
  305. Garofalo M., Pultrone C.V., Schiavina R., Brunocilla E., Sanguedolce F., et al. Tubeless procedure reduces hospitalization and pain after percutaneous nephrolithotomy: results of a multivariable analysis. Urolithiasis. 2013; №41 (4):347-53.
  306. Gonen M., Cicek T., Ozkardes H. Tubeless and stentless percutaneous nephrolithotomy in patients requiring supracostal access. Urol Int. 2009; №82 (4):440-3.
  307. Widyokirono D.R., Kloping Y.P., Hidayatullah F., Rahman Z.A., Chi-Fai Ng A., Hakim L. Endoscopic Combined Intrarenal Surgery vs Percutaneous Nephrolithotomy for Large and Complex Renal Stone: A Systematic Review and Meta-Analysis.
  308. Cracco C.M., Marco C. Scoffone 1 Endoscopic combined intrarenal surgery (ECIRS) - Tips and tricks to improve outcomes: A systematic review.
  309. Cracco C.M., Knoll T., Liatsikos E.N., Osther P.J., Smith A.D., Scarpa R.M., Scoffone C.M. Rigid-only versus combined rigid and flexible percutaneous nephrolithotomy: a systematic review. Minerva Urol Nefrol. 2017; №69(4):330-341.
  310. Widyokirono, D.R., Kloping, Y.P., Hidayatullah, F., Rahman, Z.A., Ng, A.C.F., Hakim, L. Endoscopic combined intrarenal surgery vs percutaneous nephrolithotomy for large and complex renal stone: a systematic review and meta-analysis. Journal of Endourology. 2022: №36(7): 865-876.
  311. Chen Z. H. et al. Comparison of mini endoscopic combined intrarenal surgery and multitract minimally invasive percutaneous nephrolithotomy specifically for kidney staghorn stones: a single-centre experience. BMC urology. 2022; № 22(1): 93.
  312. Wang, Z., Feng, D., Cao, D., Zhang, Y., Wei, W. Comparison of safety and efficacy between single-tract and multiple-tract percutaneous nephrolithotomy treatment of complex renal calculi: a systematic review and meta-analysis. Minerva Urology and Nephrology. 2021; № 73(6): 731-738.
  313. Jiao B., Ding Z., Luo Z., Lai S., Xu X., Chen X., et al. Single- versus Multiple-Tract Percutaneous Nephrolithotomy in the Surgical Management of Staghorn Stones or Complex Caliceal Calculi: A Systematic Review and Meta-analysis. Biomed Res Int. 2020;8817070.
  314. Reeves T., Pietropaolo A., Gadzhiev N., Seitz C., Somani B.K. Role of Endourological Procedures (PCNL and URS) on Renal Function: a Systematic Review. Curr Urol Rep. 2020; №21(5):21.
  315. Abdullatif V.A., Sur R.L., Abdullatif Z.A., Szabo S.R., Abbott J.E. The Safety and Efficacy of Endoscopic Combined Intrarenal Surgery (ECIRS) versus Percutaneous Nephrolithotomy (PCNL): A Systematic Review and Meta-Analysis. Adv Urol. 2022;1716554.
  316. Gorbachinsky I., Wood K., Colaco M., Hemal S., Mettu J., Mirzazadeh M., Assimos D.G., et al. Evaluation of Renal Function after Percutaneous Nephrolithotomy-Does the Number of Percutaneous Access Tracts Matter? J Urol. 2016; №196(1):131-6.
  317. Gravas S., Montanari E., Geavlete P., Onal B., Skolarikos A., et al. Postoperative infection rates in low risk patients undergoing percutaneous nephrolithotomy with and without antibiotic prophylaxis: a matched case control study. J Urol. 2012; №188 (3):843-7.
  318. Jung H.D., Cho K.S., Moon Y.J., Chung D.Y., Kang D.H., Lee J.Y. Antibiotic prophylaxis for percutaneous nephrolithotomy: An updated systematic review and meta-analysis. PLoS One. 2022; №17(4):e0267233.
  319. Yang, Z., Lin, D., Hong, Y. et al. The effect of preoperative urine culture and bacterial species on infection after percutaneous nephrolithotomy for patients with upper urinary tract stones. Sci Rep. 2022; №12:4833.
  320. Малхасян В.А., Семенякин И.В., Иванов В.Ю., Сухих С.О., Гаджиев Н.К. Обзор осложнений перкутанной нефролитотомии и методов их лечения. Урология. 2018; №4: 147-153.
  321. Акопян Г.Н., Аляев Ю.Г., Рапопорт Л.М., Газимиев М.А., Акопян Г.С. Осложнения перкутанной нефролитотомии: данные литературы и собственные исследования. Вопросы урологии и андрологии. 2017; №5(3): 28–34. DOI: 10.20953/2307-6631-2017-3-28-34.
  322. Vignali C., Lonzi S., Bargellini I., Cioni R., Petruzzi P., et al. Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization. Eur Radiol. 2004; №14 (4):723-9.
  323. El Tayeb M.M., Knoedler J.J., Krambeck A.E., Paonessa J.E., Mellon M.J., et al. Vascular complications after percutaneous nephrolithotomy: 10 years of experience. Urology. 2015; №85 (4):777-81.
  324. Rastinehad A.R., Andonian S., Smith A.D., Siegel D.N. Management of hemorrhagic complications associated with percutaneous nephrolithotomy. J Endourol. 2009; №23 (10):1763-7.
  325. Basiri A., Tabibi A., Nouralizadeh A., Arab D., Rezaeetalab G.H., et al. Comparison of safety and efficacy of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy in patients with renal pelvic stones: a randomized clinical trial. Urol J. 2014; №11 (6):1932-7.
  326. Beltrami P., Ruggera L., Guttilla A., Iannetti A., Zattoni F., et al. The endourological treatment of renal matrix stones. Urol Int. 2014; №93 (4):394-8.
  327. Al-Hunayan A., Khalil M., Hassabo M. et al. Management of solitary renal pelvic stone: laparoscopic retroperitoneal pyelolithotomy versus percutaneous nephrolithotomy. J. Endourol. 2011; №25 (6):975–978.
  328. Giedelman C., Arriaga J. Carmona O., de Andrade R., Banda E., et al. Laparoscopic anatrophic nephrolithotomy: developments of the technique in the era of minimally invasive surgery. J Endourol. 2012; №26 (5):444-50.
  329. Wang X., Li S., Liu T., Guo Y., Yang Z. Laparoscopic pyelolithotomy compared to percutaneous nephrolithotomy as surgical management for large renal pelvic calculi: a meta-analysis. J Urol. 2013; №190 (3):888-893.
  330. Singh V., Sinha R.J., Gupta D.K., Pandey M. Prospective randomized comparison of retroperitoneoscopic pyelolithotomy versus percutaneous nephrolithotomy for solitary large pelvic kidney stones. Urol Int. 2014; №92 (4):392-5.
  331. Wang J., Yang Y., Chen M., Tao T., Liu C., Huang Y., et al. Laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for treatment of large renal pelvic calculi (diameter >2 cm): a meta-analysis. Acta Chir Belg. 2016; №116(6):346-356.
  332. Naspro R., Rossini R., Musumeci G., Gadda F., Pozzo L.F. Antiplatelet therapy in patients with coronary stent undergoing urologic surgery: is it still no man"s land? Eur Urol. 2013; №64 (1):101-5.
  333. Baron T.H., Kamath P.S., McBane R.D. Management of antithrombotic therapy in patients undergoing invasive procedures. N Engl J Med. 2013; №368 (22):2113-24.
  334. Mullins J.K., Semins M.J., Hyams E.S., Bohlman M.E., Matlaga B.R. Half Fourier single-shot turbo spin-echo magnetic resonance urography for the evaluation of suspected renal colic in pregnancy. Urology. 2012; №79 (6):1252-5.
  335. White W.M., Zite N.B., Gash J., Waters W.B., Thompson W., et al. Low-dose computed tomography for the evaluation of flank pain in the pregnant population. J Endourol. 2007; №21 (11): с.1255-60.
  336. White W.M., Johnson E.B., Zite N.B., Beddies J., Krambeck A.E., et al. Predictive value of current imaging modalities for the detection of urolithiasis during pregnancy: a multicenter, longitudinal study. J Urol. 2013; №189 (3): с.931-4.
  337. Lloyd G.L., Lim A., Hamoui N., Nakada S.Y., Kielb S.J. The Use of Medical Expulsive Therapy During Pregnancy: A Worldwide Perspective Among Experts. J Endourol. 2016; №30 (3):354-8.
  338. Blanco LT, Socarras MR, Montero RF, et al. Renal colic during pregnancy: Diagnostic and therapeutic aspects. Literature review. Cent European J Urol. 2017;70(1):93–100.
  339. Semins M.J., Trock B.J., Matlaga B.R. The safety of ureteroscopy during pregnancy: a systematic review and meta-analysis. J Urol. 2009; №181 (1):139-43.
  340. Parulkar B.G., Hopkins T.B., Wollin M.R., Howard P.J. Jr, Lal A. Renal colic during pregnancy: a case for conservative treatment. J Urol. 1998; №159 (2):365-8.
  341. Asgari M.A., Safarinejad M.R., Hosseini S.Y., Dadkhah F. Extracorporeal shock wave lithotripsy of renal calculi during early pregnancy. BJU Int. 1999; №84:615–617.
  342. Tóth C., Tóth G., Varga A., Flaskó T., Salah M.A. Percutaneous nephrolithotomy in early pregnancy. Int Urol Nephrol. 2005; №37(1):1-3. 
  343. Shah A., Chandak P., Tiptaft R., Glass J., Dasgupta P. Percutaneous nephrolithotomy in early pregnancy. Int J Clin Pract. 2004; №58 (8):809-10.
  344. Fregonesi A., Dias F.G., Saade R.D., Dechaalani V., Reis L.O. Challenges on percutaneous nephrolithotomy in pregnancy: Supine position approach through ultrasound guidance. Urol Ann. 2013; №5 (3):197-9.
  345. Kamphuis G.M., Baard J., Westendarp M., de la Rosette J.J. Lessons learned from the CROES percutaneous nephrolithotomy global study. World J Urol. 2015; №33 (2):223-33.
  346. Committee on Obstetric Practice and the American Society of Anesthesiologists. Committee Opinion No. 696: Nonobstetric Surgery During Pregnancy. Obstet Gynecol. 2017; №129 (4):777-778.
  347. Ishii H., Aboumarzouk O.M., Somani B.K. Current status of ureteroscopy for stone disease in pregnancy. Urolithiasis. 2014; №42 (1):1-7.
  348. Watterson J.D., Girvan A.R., Beiko D.T., Nott L., Wollin T.A., et al. Ureteroscopy and holmium:YAG laser lithotripsy: an emerging definitive management strategy for symptomatic ureteral calculi in pregnancy. Urology. 2002; №60 (3):383-7.
  349. Scotland K.B., Lange D. Prevention and management of urosepsis triggered by ureteroscopy. Res Rep Urol. 2018; №10:43-49.
  350. Delvecchio F.C., Kuo R.L., Iselin C.E., Webster G.D., Preminger G.M. Combined antegrade and retrograde endoscopic approach for the management of urinary diversion-associated pathology. J Endourol. 2000; №14 (3):251-6.
  351. Cohen T.D., Streem S.B., Lammert G. Long-term incidence and risks for recurrent stones following contemporary management of upper tract calculi in patients with a urinary diversion. J Urol. 1996; №155 (1):62-5.
  352. Grasso M. Ureteropyeloscopic treatment of ureteral and intrarenal calculi. Urol Clin North Am. 2000; №27 (4):623-31.
  353. Golomb J., Fuchs G., Klutke C.G., Stenzl A., Raz S. Kidney stone formed around refluxed surgical staple and removed by transureteral endoscopic manipulation. Urology. 1991; №38 (4):338-40.
  354. Stein J.P., Freeman J.A., Esrig D., Elmajian D.A., Tarter T.H., et al. Complications of the afferent antireflux valve mechanism in the Kock ileal reservoir. J Urol. 1996; №155 (5): с.1579-84.
  355. Weinerth J.L., Webster G.D. Experience with management of stones formed within Kock pouch continent urinary diversions. Journal of Endourology. 1990; №4 (2): 149-154.
  356. Beiko D.T., Razvi H. Stones in urinary diversions: update on medical and surgical issues. Curr Opin Urol. 2002; №12 (4):297-303.
  357. Matlaga B.R., Shah O.D., Zagoria R.J., Dyer R.B., Streem S.B., et al. Computerized tomography guided access for percutaneous nephrostolithotomy. J Urol. 2003; №170 (1):45-7.
  358. Trivedi A., Patel S., Devra A., Rizvi J, Goel R., et al. Management of calculi in a donor kidney. Transplant Proc. 2007; №39 (3): 761-2.
  359. Rifaioglu M.M., Berger A.D., Pengune W., Stoller M.L. Percutaneous management of stones in transplanted kidneys. Urology. 2008; №72 (3):508-12.
  360. Keoghane S.R., Cetti R.J., Rogers A.E., Walmsley B.H. Blood transfusion, embolisation and nephrectomy after percutaneous nephrolithotomy (PCNL). BJU Int. 2013; №111 (4):628-32.
  361. Richstone L., Reggio E., Ost M.C., Seideman C., Fossett L.K., et al. First Prize (tie): Hemorrhage following percutaneous renal surgery: characterization of angiographic findings. J Endourol. 2008; №22 (6):1129-35.
  362. Nouralizadeh A., Ziaee S.A., Hosseini Sharifi S.H., Basiri A., Tabibi A., et al. Delayed postpercutaneous nephrolithotomy hemorrhage: prevalence, predictive factors and management. Scand J Urol. 2014; №48 (1):110-5.
  363. Valecha N.K., Bagheri F., Hassani S., Sadi A., Souliman R. Delayed Haematuria after Percutaneous Nephrolithotripsy and its Management. Med Sur Urol. 2017; №6(3): 189.
  364. Pawar A.S., et al. Incidence and characteristics of kidney stones in patients with horseshoe kidney: A systematic review and meta-analysis. Urol Ann, 2018; №10: 87.
  365. Moe OW. Kidney stones: pathophysiology and medical management. Lancet. 2006 Jan 28;367(9507):333-44
  366. Fink H.A., et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013; №158: 535-43.
  367. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, Kane RL, Ouellette J, Monga M. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.Erratum in: Ann Intern Med. 2013 Aug 6;159(3):230-2
  368. Addessi A, Gambaro G. Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature. J Nephrol. 2017 Apr;30(2):227-233
  369. Dauw CA, Yi Y, Bierlein MJ, Yan P, Alruwaily AF, Ghani KR, Wolf JS Jr, Hollenbeck BK, Hollingsworth JM. Medication Nonadherence and Effectiveness of Preventive Pharmacological Therapy for Kidney Stones. J Urol. 2016 Mar;195(3):648-52.
  370. Dissayabutra, T., et al. Urinary stone risk factors in the descendants of patients with kidney stone disease. Pediatr Nephrol, 2018; №33: 1173.
  371. Hu H., et al. Association between Circulating Vitamin D Level and Urolithiasis: A Systematic Review and Meta-Analysis. Nutrients, 2017; 9.
  372. Eraghty R.M., et al. Worldwide Impact of Warmer Seasons on the Incidence of Renal Colic and Kidney Stone Disease: Evidence from a Systematic Review of Literature. J Endourol, 2017; №31: 729.
  373. Guo Z.L., et al. Association between cadmium exposure and urolithiasis risk: A systematic review and meta-analysis. Medicine (Baltimore), 2018; 97: e9460.
  374. Goldfarb D.S., et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int, 2005; №67: 1053.
  375. Gonzalez, R.D., et al. Kidney stone risk following modern bariatric surgery. Curr Urol Rep. 2014; №15: 401.
  376. Rendina, D., et al. Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol, 2014; №27: 371.
  377. Dell’Orto V.G., et al. Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review. Br J Clin Pharmacol, 2014; № 77: 958.
  378. Mollerup C.L., Vestergaard P. et al. Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ 2002; №325: 807.
  379. Дедов И.И., Мельниченко Г.А., Мокрышева Н.Г., Рожинская Л.Я., Кузнецов Н.С., Пигарова Е.А., и др. Первичный гиперпаратиреоз: клиника, диагностика, дифференциальная диагностика, методы лечения В сборнике: Актуальные вопросы современной эндокринологической практики. материалы мультидисциплинарной конференции. 2016; 49-52.
  380. Parks J.H., et al. A single 24-hour urine collection is inadequate for the medical evaluation of nephrolithiasis. J Urol. 2002; №167: 1607.
  381. Nayan M., et al. Variations between two 24-hour urine collections in patients presenting to a tertiary stone clinic. Can Urol Assoc J. 2012; №6: 30.
  382. Williams J.C., Jr., et al. Urine and stone analysis for the investigation of the renal stone former: a consensus conference. Urolithiasis, 2021; №49:1
  383. Norman R.W., Bath S.S., Robertson W.G., Peacock M. When should patients with symptomatic urinary stone disease be evaluated metabolically? J Urol. 1984; №132(6):1137-9.
  384. Ferraz R.R., et al. Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res. 2006; № 34: 329.
  385. Wagner C.A., et al. Urinary pH and stone formation. J Nephrol. 2010; № 23 Suppl 16: S165.
  386. Pak C.Y., Poindexter J.R., Adams-Huet B. et al: Predictive value of kidney stone composition in the detection of metabolic abnormalities. Am J Med. 2004; №115: 26.
  387. Rath B., Aggarwal M.K., Mishra T.K., Talukdar B., Murthy N.S., Kabi B.C. Urinary calcium creatinine ratio and hypercalciuria. Indian Pediatr. 1994; №31(3):311-6.
  388. Parks J.H., Coward M., Coe F.L: Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997; №51: 894.
  389. Asplin J., Parks J., Lingeman J. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1988; №159: 1821.
  390. Kourambas J, Aslan P, Teh CL et al: Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol 2001; 15: 181
  391. Kocvara R, Plasqura P, Petrik A et al: A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int. 1999; №84: 393
  392. Pearle M.S., et al. Medical management of urolithiasis. 2nd International Consultation on Stone Disease, editor. K.S. Denstedt J. 2008.
  393. Matlaga B.R., et al. Drug-induced urinary calculi. Rev Urol. 2003; №5: 227.
  394. Assimos H.M., Chew B D., Hautmann R., Holmes R., Williams J., et al. Evaluation of the Stone Former. 2nd International consultation on Stone Disease. Health Publications, 2008: 31-56.
  395. Türk C., Petřík A., Sarica K., Seitz C., Skolarikos A., et al. EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2016; №69 (3): с.475-82.
  396. Assimos D., Chew B., Hautmann R., Holmes R., Williams J., Wolf J.S. Urine evaluation In: Evaluation of the stone former, in 2nd International Consultation on Stone Disease, Editors. 2007, Health Publications.
  397. Pearle M.S., et al. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999; №13: 679.
  398. Carpentier X., et al. Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology. 2009; № 73: 968.
  399. Dhayat N.A., et al. Furosemide/Fludrocortisone Test and Clinical Parameters to Diagnose Incomplete Distal Renal Tubular Acidosis in Kidney Stone Formers. Clin J Am Soc Nephrol. 2017; № 12: 1507.
  400. Sromicki J., et al. Prospective long-term evaluation of incomplete distal renal tubular acidosis in idiopathic calcium nephrolithiasis diagnosed by low-dose NH4CL loading - gender prevalences and impact of alkali treatment. J Nephrol. 2022; №35: 1619.
  401. Alper S.L. Familial renal tubular acidosis. J. Nephrol. 2010; 23 Suppl 16: 57-76.
  402. Batlle D., Haque S.K. Genetic causes and mechanisms of distal renal tubular acidosis. Nephrol. Dial. Transplant. 2012; 27(10): 3691-3704
  403. Pierre C., Gill R. Primary hyperoxaluria. N Engl J Med. 2013;
  404. Asplin J.R. The management of patients with enteric hyperoxaluria. Urolithiasis. 2016; №44: 33.
  405. Hoppe B., et al. Diagnostic and therapeutic approaches in patients with secondary hyperoxaluria. Front Biosci. 2003; 8:437.
  406. Borghi L., Meschi T., Amato F., Briganti A., Novarini A., et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996; № 155 (3): 839-43.
  407. Shuster J., Jenkins A., Logan C., Barnett T., Riehle R., et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. 1992; № 45(8): 911- 6.
  408. Curhan G.C., Willett W.C., Rimm E.B., Stampfer M.J. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993; № 328 (12): 833-8.
  409. Curhan G.C., Willett W.C., Speizer F.E., Spiegelman D., Stampfer M.J. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997; № 126(7): 497-504.
  410. Harris S.S., Dawson-Hughes B. Effects of Hydration and Calcium Supplementation on Urine Calcium Concentration in Healthy Postmenopausal Women. J Am Coll Nutr. 2015; № 34(4): 340-6.
  411. Borghi L., Schianchi T., Meschi T., Guerra A., Allegri F., et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; № 346 (2): 77-84.
  412. Fink H.A., Akornor J.W., Garimella P.S., MacDonald R., Cutting A., et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. 2009; № 56(1): 72-80.
  413. Ebisuno S., et al. Results of long-term rice bran treatment on stone recurrence in hypercalciuric patients. Br J Urol. 1991; №67: 237.
  414. Hiatt R.A., et al. Randomized controlled trial of a low animal protein, high fiber diet in the prevention of recurrent calcium oxalate kidney stones. Am J Epidemiol. 1996; №144: 25.
  415. Dussol, B., et al. A randomized trial of low-animal-protein or high-fiber diets for secondary prevention of calcium nephrolithiasis. Nephron Clin Pract. 2008; № 110: 185.
  416. Turney B.W., et al. Diet and risk of kidney stones in the Oxford cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC). Eur J Epidemiol. 2014; №29: 363.
  417. База данных «Химический состав пищевых продуктов, используемых в Российской Федерации» - эл. ресурс: URL: http://web.ion.ru/food/FD_tree_grid.aspx/ дата обращения 10.05.2023
  418. Cappuccio F.P., Kalaitzidis R., Duneclift S., Eastwood J.B., Unravelling the links between calcium excretion, salt intake, hypertension, kidney stones and bone metabolism. J NEPHROL 2000; №13: 169-177.
  419. Nordin B.E., Need A.G., Steurer T., Morris H.A,. Chatterton B E, Horowitz M. Nutrition, osteoporosis, and aging. Ann N Y Acad Sci. 1998; №854:336-51.
  420. Barcelo P., et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol, 1993; № 150: 1761.
  421. Hofbauer, J., et al. Alkali citrate prophylaxis in idiopathic recurrent calcium oxalate urolithiasis—a prospective randomized study. Br J Urol. 1994; №73: 362.
  422. Ettinger B., et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997; №158: 2069.
  423. Lojanapiwat B., et al. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Int Braz J Urol. 2011; №37: 611.
  424. Phillips R., et al. Citrate salts for preventing and treating calcium containing kidney stones in adults. Cochrane Database Syst Rev. 2015: CD010057.
  425. Pinheiro V.B., et al. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Urology. 2013; №82: 33.
  426. Pak C.Y., Koenig K., Khan R., Haynes S., Padalino P. Physicochemical action of potassium-magnesium citrate in nephrolithiasis. J Bone Miner Res. 1992; №7(3): 281-5.
  427. Galan-Llopis J.A., Torrecilla-Ortiz C., Luque-Gálvez M.P., Group P-L., Peris-Nieto X., Cuñé-Castellana J. Urinary pH as a Target in the Management of Lithiasic Patients in Real-World Practice: Monitoring and Nutraceutical Intervention for a Nonlithogenic pH Range. Clinical Medicine Insights. Urology. 2019; №12: 1-8.
  428. Grases F., Rodriguez A., Costa-Bauza A. Theobromine inhibits uric acid crystallization. A potential application in the treatment of uric acid nephrolithiasis. PLoS One. 2014; №9(10):e111184.
  429. Chattaraj KG, Paul S. Inclusion of Theobromine Modifies Uric Acid Aggregation with Possible Changes in Melamine-Uric Acid Clusters Responsible for Kidney Stones. J Phys Chem B. 2019; №123(49):10483-10504.
  430. Preminger G.M., Sakhaee K., Pak C.Y. Alkali action on the urinary crystallization of calcium salts: contrasting responses to sodium citrate and potassium citrate. J Urol. 1988; №139(2):240-2.
  431. Sakhaee K., Nicar M., Hill K., Pak C.Y. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int. 1983; №24(3):348-52.
  432. Pinheiro V.B., Baxmann A.C., Tiselius HG, Heilberg IP. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers. Urology. 2013 Jul;82(1):33-7.
  433. Просянников М.Ю., Константинова О.В., Голованов С.А., Анохин Н.В., Войтко Д.А., Сивков А.В., и др. Роль щелочных цитратов в метафилактике мочекаменной болезни. Урология. 2022; № 3: 19-25.
  434. Fegan J., Khan R., Poindexter J., Pak C.Y. Gastrointestinal citrate absorption in nephrolithiasis. J Urol. 1992; №147(5):1212-4.
  435. Unwin R.J., Capasso G., Shirley D.G. An overview of divalent cation and citrate handling by the kidney. Nephron Physiol. 2004; №98(2):p15-20.
  436. Zacchia M., Preisig P. Low urinary citrate: an overview. J Nephrol. 2010; №23 Suppl 16:S49-56. PMID: 21170889
  437. Ettinger B. Hyperuricosuric calcium stone disease, In: Kidney Stones. Medical and Surgical Management,
  438. Coe F.L., Pak C.Y.C., Parks J.H., Preminger G.M., Editor. 1996, Lippincott-Raven: Philadelphia.
  439. Coe F.L. Hyperuricosuric calcium oxalate nephrolithiasis. Adv Exp Med Biol. 1980;№128:439-50.
  440. Favus, M.J., et al. The effects of allopurinol treatment on stone formation on hyperuricosuric calcium oxalate stone-formers. Scand J Urol Nephrol Suppl, 1980; ;№53: 265.
  441. Ettinger, B., et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med, 1986. 315: 1386.
  442. Smith, M.J. Placebo versus allopurinol for renal calculi. J Urol, 1977; №117: 690.
  443. Goldfarb, D.S., et al. Randomized controlled trial of febuxostat versus allopurinol or placebo in individuals with higher urinary uric acid excretion and calcium stones. Clin J Am Soc Nephrol. 2013; №8: 1960.
  444. Nouvenne, A., et al. New pharmacologic approach to patients with idiopathic calcium nephrolithiasis and high uricosuria: Febuxostat vs allopurinol. A pilot study. Eur J Int Med. 2013; №24: e64.
  445. Brocks, P., et al. Do thiazides prevent recurrent idiopathic renal calcium stones? Lancet, 1981; №2: 124.
  446. Mortensen, J.T., et al. Thiazides in the prophylactic treatment of recurrent idiopathic kidney stones. Int Urol Nephrol, 1986; №18: 265.
  447. Wolf, H., et al. Do thiazides prevent recurrent idiopathic renal calcium oxalate stones? Proc Eur Dial Transplant Assoc, 1983; №20: 477.
  448. Pedersen, S.A., et al. Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark. J Am Acad Dermatol. 2018; №78: 673.
  449. Pottegård, A., et al. Hydrochlorothiazide use is strongly associated with risk of lip cancer. J Intern Med. 2017; №282: 322.
  450. Pottegard, A., et al. Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma. JAMA Intern Med. 2018; №178: 1120.
  451. Nakagawa, Y., et al. Clinical use of cystine supersaturation measurements. J Urol. 2000; № 164: 1481.
  452. Fjellstedt, E., et al. Cystine analyses of separate day and night urine as a basis for the management of patients with homozygous cystinuria. Urol Res. 2001; №29: 303.
  453. Rogers, A., et al. Management of cystinuria. Urol Clin North Am. 2007; №34: 347.
  454. Ng, C.S., et al. Contemporary management of cystinuria. J Endourol. 1999; №13: 647.
  455. Biyani, C.S., et al. Cystinuria—diagnosis and management. EAU-EBU Update Series 2006; №4: 175.
  456. Knoll, T., et al. Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up. Pediatr Nephrol. 2005; №20: 19.
  457. Cohen, T.D., et al. Clinical effect of captopril on the formation and growth of cystine calculi. J Urol. 1995; №154: 164.
  458. Coulthard, M.G., et al. The treatment of cystinuria with captopril. Am J Kidney Dis. 1995; №25: 661.
  459. Dolin, D.J., et al. Effect of cystine-binding thiol drugs on urinary cystine capacity in patients with cystinuria. J Endourol. 2005; №19: 429.
  460. Chow, G.K., et al. Medical treatment of cystinuria: results of contemporary clinical practice. J Urol. 1996; №156: 1576.
  461. Pak, C.Y., et al. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. J Urol. 1986; №136: 1003.
  462. Tekin, A., et al. Cystine calculi in children: the results of a metabolic evaluation and response to medical therapy. J Urol. 2001; №165: 2328.
  463. Hoppe B., et al. The primary hyperoxalurias. Kidney Int. 2009; №75: 1264-1271.
  464. Leumann E, Hoppe B. The primary hyperoxalurias. J Am Soc Nephrol. 2001; №12(9):1986-1993.
  465. Rumsby G, Williams E, Coulter-Mackie M. Evaluation of mutation screening as a first line test for the diagnosis of the primary hyperoxalurias. Kidney Int. 2004; №66(3):959-63.
  466. Garrelfs, S.F., et al. Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1. N Engl J Med. 2021; №384: 1216.
  467. Leumann E, Hoppe B, Neuhaus T. Management of primary hyperoxaluria: efficacy of oral citrate administration. Pediatr Nephrol. 1993; №7(2): 207-11.
  468. Hamm LL. Renal handling of citrate. Kidney Int. 1990; №38(4):728-35.
  469. Von Unruh, G.E., et al. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004; №15: 1567.
  470. Jarrar K, Boedeker R.H., Weidner W.K. Struvite stones: long term follow up under metaphylaxis. Ann Urol (Paris). 1996; №30(3):112-7.
  471. Torrecilla C, Fernández-Concha J, Cansino JR, Mainez JA, Amón JH, Costas S, Angerri O, Emiliani E, Arrabal Martín MA, Arrabal Polo MA, García A, Reina MC, Sánchez JF, Budía A, Pérez-Fentes D, Grases F, Costa-Bauzá A, Cuñé J. Reduction of ureteral stent encrustation by modulating the urine pH and inhibiting the crystal film with a new oral composition: a multicenter, placebo controlled, double blind, randomized clinical trial. BMC Urol. 2020; №20(1):65.
  472. Grases F, Ramis M, Costa-Bauzá A. Effects of phytate and pyrophosphate on brushite and hydroxyapatite crystallization. Comparison with the action of other polyphosphates. Urol Res. 2000; №28(2):136-40.
  473. Gettman, M.T., et al. Struvite stones: diagnosis and current treatment concepts. J Endourol. 1999; №13: 653.
  474. Kramer, G., et al. Role of bacteria in the development of kidney stones. Curr Opin Urol. 2000; №10: 35.
  475. Bichler, K.H., et al. Urinary infection stones. Int J Antimicrob Agents. 2002; №19: 488.
  476. Carpentier, X., et al. Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology. 2009; №73: 968.
  477. Flannigan R, Choy WH, Chew B, Lange D. Renal struvite stones--pathogenesis, microbiology, and management strategies. Nat Rev Urol. 2014; №11(6):333-41. doi: 10.1038/nrurol.2014.99. Epub 2014 May 13. Erratum in: Nat Rev Urol. 2014 Jun;11(6):page after 341.
  478. Abou Chakra M, Dellis AE, Papatsoris AG, Moussa M. Established and recent developments in the pharmacological management of urolithiasis: an overview of the current treatment armamentarium. Expert Opin Pharmacother. 2020; №21(1):85-96.
  479. Перепанова Т.С., Козлов Р.С., Дехнич А.В., Палагин И.С., Шевелев А.Н., Волкова Е.М., Эгамбердиев Д. Выбор антимикробных препаратов при инфекции мочевыводящих путей. Урология. 2012; № 2: 4-8.
  480. Просянников М.Ю., Константинова О.В., Голованов С.А., Анохин Н.В.,Войтко Д.А. Результаты применения препарата растительного происхождения с антиоксидантной защитой при мочекаменной болезни.  Урология. 2020; №4: 55-59.
  481. Камалов А.А., Охоботов Д.А., Проскурнина Е.В., Созарукова М.М., НизовА.Н. Антиоксидантная активность и клиническая эффективность биологически активной добавки нефрадоз в лечении рецидивирующего кальций-оксалатного уролитиаза. Урология. 2018; №6: 52-59.
  482. Просянников М.Ю., Мазуренко Д.А., Константинова О.В. и др. Результаты оценки влияния растительного препарата с комплексом биологически активных компонентов на биохимические показатели мочи у больных мочекаменной болезнью. Экспериментальная и клиническая урология. 2019; № 4: 40-47. 
  483. Grases F, Rodriguez A, Costa-Bauza A. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine. J Urol. 2015 Sep;194(3):812-9
  484. Grases F, Prieto RM, Fernandez-Cabot RA, Costa-Bauzá A, Tur F, Torres JJ. Effects of polyphenols from grape seeds on renal lithiasis. Oxid Med Cell Longev. 2015;2015:813737. Epub 2015 Mar 25.
  485. Guimerà J, Martínez A, Bauza JL, Sanchís P, Pieras E, Grases F. Effect of phytate on hypercalciuria secondary to bone resorption in patients with urinary stones: pilot study. Urolithiasis. 2022;50(6):685-690.
  486. Conte A, Pizá P, García-Raja A. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate). Arch Esp Urol. 1999;52(1):94-9.
  487. Grases F, Costa-Bauzá A, Calvó P, Julià F, Dietrich J, Gomila RM, Martorell G, Sanchis P. Phytate Dephosphorylation Products Also Act as Potent Inhibitors of Calcium Oxalate Crystallization. Molecules. 2022;27(17):5463.
  488. Grases F, Costa-Bauza A. Key Aspects of Myo-Inositol Hexaphosphate (Phytate) and Pathological Calcifications. Molecules. 2019;24(24):4434
  489. Grases F, Rodriguez A, Costa-Bauza A. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine. J Urol. 2015;194(3):812-9.
  490. Turki K, Charradi K, Boukhalfa H, Belhaj M, Limam F, Aouani E. Grape seed powder improves renal failure of chronic kidney disease patients. EXCLI J. 2016;15:424-433.
  491. Grases F, Prieto RM, Fernandez-Cabot RA, Costa-Bauzá A, Tur F, Torres JJ. Effects of polyphenols from grape seeds on renal lithiasis. Oxid Med Cell Longev. 2015;2015:813737.
  492. Riley JM, Kim H, Averch TD, Kim HJ. Effect of magnesium on calcium and oxalate ion binding. J Endourol. 2013 Dec;27(12):1487-92.
  493. Mardis HK, Parks JH, Muller G et al: Outcome of metabolic evaluation and medical treatment for calcium nephrolithiasis in a private urological practice. J Urol 2004; 171: 85,
  494. Pak CY, Heller HJ, Pearle MS et al: Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 2003; 169: 465.
  495. Tzelves, L., et al. Duration of Follow-up and Timing of Discharge from Imaging Follow-up, in Adult Psatients with Urolithiasis After Surgical or Medical Intervention: A Systematic Review and Meta-analysis from the European Association of Urology Guideline Panel on Urolithiasis. Eur Urol Focus, 2022.
  496. Wang Z, He X, Bai Y, Wang J. Can tranexamic acid reduce the blood transfusion rate in patients undergoing percutaneous nephrolithotomy? A systematic review and meta-analysis. J Int Med Res. 2020 Apr;48(4):300060520917563.
  497. Feng D, Zhang F, Liu S, Han P, Wei W. Efficacy and safety of the tranexamic acid in reducing blood loss and transfusion requirements during percutaneous nephrolithotomy: a systematic review and meta-analysis of randomized controlled trials. Minerva Urol Nefrol. 2020 Oct;72(5):579-585.
  498. Lee MJ, Kim JK, Tang J, Ming JM, Chua ME. The Efficacy and Safety of Tranexamic Acid in the Management of Perioperative Bleeding After Percutaneous Nephrolithotomy: A Systematic Review and Meta-Analysis of Comparative Studies. J Endourol. 2022 Mar;36(3):303-312.
  499. Kallidonis P, Vagionis A, Pagonis K, Peteinaris A, Pietropaolo A, Adamou C, Liatsikos E, Tailly T. Is There Any Clinical Benefit for Peri-operative Administration of Tranexamic Acid for Patients Undergoing Percutaneous Nephrolithotomy? A Systematic Review and Meta-analysis. Curr Urol Rep. 2021 Dec 16;22(12):65.
  500. MacDonald M, Ilie G, Power L, Whalen S, Parker R, Skinner TA, Powers AGL. Effect of Tranexamic Acid on Bleeding Outcomes After Percutaneous Nephrolithotomy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. J Endourol. 2022 May;36(5):589-597.
  501. Baccaglini W, Rodrigues AF, Glina FPA, DallAqua V, Glina S, Neto ACL. Tranexamic Acid Use for Hemorrhagic Events Prevention in Percutaneous Nephrolithotomy: Systematic Review and Meta-Analysis. J Endourol. 2022 Jul;36(7):906-915.
  502. Prasad S, Sharma G, Devana SK, Kumar S, Sharma S. Is tranexamic acid associated with decreased need for blood transfusion in percutaneous nephrolithotomy: a systematic review and meta-analysis. Ann R Coll Surg Engl. 2023 Feb;105(2):99-106.
  503. Robinson MR, Leitao VA, Haleblian GE et al: Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. J Urol 2009; 181: 1145.
  504. Просянников М.Ю., Шадеркин И.А., Константинова О.В., Анохин Н.В., Войтко Д.А., Никушина А.А. Дистанционный мониторинг показателей общего анализа мочи при лечении цитратными смесями пациентов с мочекислым уролитиазом Урология. 2019. № 3. С. 60-65.
  505. Глыбочко П.В., Аляев Ю.Г., Рапопорт Л.М., Цариченко Д.Г., Фролова Е.А. Современная консервативная (цитратная) терапия при уратных камнях мочеточников. Урология. 2014. № 5. С. 10-13.
  506. Ong A, Brown G, Tokas T, Hameed BMZ, Philip J, Somani BK. Selection and Outcomes for Dissolution Therapy in Uric Acid Stones: A Systematic Review of Literature. Curr Urol Rep. 2023 Aug;24(8):355-363. doi: 10.1007/s11934-023-01164-7. Epub 2023 Apr 20. PMID: 37079196.
  507. Газимиев М.А., Песегов С.В., Аляев Ю.Г. «Мочекаменная болезнь». Часть 5. Лекарственные средства, применяемые в медикаментозной метафилактике мочекаменной болезни. Урология, 2019, №3, с.156-164
  508. Фролова Е.А., Цариченко Д.Г, Рапопорт Л.М., Глыбочко П.В. Растворение мочекислых камней мочеточника. Урология. 2022. № 6. С. 56-60. DOI: https://dx.doi.org/10.18565/urology.2022.6.56-60
  509. Стрельцова О.С., Ляхова А.А., Яшанова М.И., Кашина А.Ю., Калашников И.Н., Почтин Д.П., Гребенкин Е.В., Влияние комплекса натуральных терпенов и витамина Е Ренотинекс® на свободнорадикальные процессы у пациентов с мочекаменной болезнью., Урологические ведомости Том 13, №1, 2023  (ссылка 509)
  510. Котов С.В., Неменов А.А., Перов Р.А. Эффективность комбинированной фитотерапии (НефроБест® в сочетании с УроБест®) у женщин с уретеролитиазом на фоне дренирования мочевых путей перед уретероскопией. Вестник урологии. 2024;12(1) (ссылка 510)
  511. Al-Dessoukey AA, Abdallah M, Moussa AS, et al. Ultraslow full-power shock wave lithotripsy versus slow power-ramping shock wave lithotripsy in stones with high attenuation value: A randomized comparative study. Int J Urol 2020;27:165-70. 10.1111/iju.14158
  512. Ng C fai, Yee CH, Teoh JYC, Lau B, Leung SCH, Wong CYP, et al. Effect of Stepwise Voltage Escalation on Treatment Outcomes following Extracorporeal Shock Wave Lithotripsy of Renal Calculi: A Prospective Randomized Study. Journal of Urology [Internet]. 2019
  513. Kang SK, Cho KS, Kang DH, Jung HD, Kwon JK, Lee JY. Systematic review and meta-analysis to compare success rates of retrograde intrarenal surgery versus percutaneous nephrolithotomy for renal stones >2 cm: An update. Medicine (Baltimore). 2017 Dec;96(49):e9119. doi: 10.1097/MD.0000000000009119
  514. Zewu Z, Cui Y, Feng Z, Yang L, Chen H. Comparison of retrograde flexible ureteroscopy and percutaneous nephrolithotomy in treating intermediate size renal stones (2-3cm): a meta-analysis and systematic review. Int Braz J Urol. 2019 Jan-Feb;45(1):10-22. doi: 10.1590/S1677-5538.IBJU.2018.0510.
  515. Kim CH, Chung DY, Rha KH, Lee JY, Lee SH. Effectiveness of Percutaneous Nephrolithotomy, Retrograde Intrarenal Surgery, and Extracorporeal Shock Wave Lithotripsy for Treatment of Renal Stones: A Systematic Review and Meta-Analysis. Medicina (Kaunas). 2020 Dec 30;57(1):26. doi: 10.3390/medicina57010026.
  516. Barone B, Crocetto F, Vitale R, Di Domenico D, Caputo V, Romano F, De Luca L, Bada M, Imbimbo C, Prezioso D. Retrograde intra renal surgery versus percutaneous nephrolithotomy for renal stones >2 cm. A systematic review and meta-analysis. Minerva Urol Nefrol. 2020 Aug;72(4):441-450. doi: 10.23736/S0393-2249.20.03721-2. Epub 2020 Feb 19.
  517. Wu P, Wang L, Wang K. Supine versus prone position in percutaneous nephrolithotomy for kidney calculi: a meta-analysis. Int Urol Nephrol. 2011 Mar;43(1):67-77. doi: 10.1007/s11255-010-9801-0. Epub 2010 Jul 14.
  518. Zhang X, Xia L, Xu T, Wang X, Zhong S, Shen Z. Is the supine position superior to the prone position for percutaneous nephrolithotomy (PCNL)? Urolithiasis. 2014 Feb;42(1):87-93. doi: 10.1007/s00240-013-0614-3. Epub 2013 Oct 20.
  519. Li J, Gao L, Li Q, Zhang Y, Jiang Q. Supine versus prone position for percutaneous nephrolithotripsy: A meta-analysis of randomized controlled trials. Int J Surg. 2019 Jun;66:62-71. doi: 10.1016/j.ijsu.2019.04.016. Epub 2019 Apr 26.
  520. Birowo P, Tendi W, Widyahening IS, Rasyid N, Atmoko W. Supine versus prone position in percutaneous nephrolithotomy: a systematic review and meta-analysis. F1000Res. 2020 Apr 2;9:231. doi: 10.12688/f1000research.22940.3.
  521. Keller EX, DE Coninck V, Proietti S, Talso M, Emiliani E, Ploumidis A, Mantica G, Somani B, Traxer O, Scarpa RM, Esperto F; European Association of Urology - European Society of Residents in Urology (EAU-ESRU). Prone versus supine percutaneous nephrolithotomy: a systematic review and meta-analysis of current literature. Minerva Urol Nephrol. 2021 Feb;73(1):50-58. doi: 10.23736/S2724-6051.20.03960-0. Epub 2020 Oct 5.
  522. Yang YH, Wen YC, Chen KC, Chen C. Ultrasound-guided versus fluoroscopy-guided percutaneous nephrolithotomy: a systematic review and meta-analysis. World J Urol. 2019 May;37(5):777-788. doi: 10.1007/s00345-018-2443-z. Epub 2018 Sep 22.
  523. Castellani D, Corrales M, Lim EJ, Cracco C, Scoffone CM, Teoh JY, Traxer O, Gauhar V. The Impact of Lasers in Percutaneous Nephrolithotomy Outcomes: Results from a Systematic Review and Meta-Analysis of Randomized Comparative Trials. J Endourol. 2022 Feb;36(2):151-157. doi: 10.1089/end.2021.0507.
  524. Jung HD, Cho KS, Moon YJ, Chung DY, Kang DH, Lee JY. Antibiotic prophylaxis for percutaneous nephrolithotomy: An updated systematic review and meta-analysis. PLoS One. 2022 Apr 15;17(4):e0267233. doi: 10.1371/journal.pone.0267233.
  525. Danilovic A, Talizin TB, Torricelli FCM, Marchini GS, Batagello C, Vicentini FC, Nahas WC, Mazzucchi E. One week pre-operative oral antibiotics for percutaneous nephrolithotomy reduce risk of infection: a systematic review and meta-analysis. Int Braz J Urol. 2023 Mar-Apr;49(2):184-193. doi: 10.1590/S1677-5538.IBJU.2022.0544.
  526. Dehong C, Liangren L, Huawei L, Qiang W. A comparison among four tract dilation methods of percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2013 Nov;41(6):523-30. doi: 10.1007/s00240-013-0598-z. Epub 2013 Aug 23.
  527. Li Y, Yang L, Xu P, Shen P, Qian S, Wei W, Wang J. One-shot versus gradual dilation technique for tract creation in percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2013 Oct;41(5):443-8. doi: 10.1007/s00240-013-0583-6. Epub 2013 Jun 18.
  528. Yuan H, Zheng S, Liu L, Han P, Wang J, Wei Q. The efficacy and safety of tubeless percutaneous nephrolithotomy: a systematic review and meta-analysis. Urol Res. 2011 Oct;39(5):401-10. doi: 10.1007/s00240-010-0355-5. Epub 2011 Jan 30.
  529. Ni S, Qiyin C, Tao W, Liu L, Jiang H, Hu H, Han R, Wang C. Tubeless percutaneous nephrolithotomy is associated with less pain and shorter hospitalization compared with standard or small bore drainage: a meta-analysis of randomized, controlled trials. Urology. 2011 Jun;77(6):1293-8. doi: 10.1016/j.urology.2010.10.023. Epub 2011 Jan 22.
  530. Wang J, Zhao C, Zhang C, Fan X, Lin Y, Jiang Q. Tubeless vs standard percutaneous nephrolithotomy: a meta-analysis. BJU Int. 2012 Mar;109(6):918-24. doi: 10.1111/j.1464-410X.2011.10463.x. Epub 2011 Aug 24.
  531. Wang J, Zhang C, Tan G, Yang B, Chen W, Tan D. The use of adjunctive hemostatic agents in tubeless percutaneous nephrolithotomy: a meta-analysis. Urolithiasis. 2014 Dec;42(6):509-17. doi: 10.1007/s00240-014-0717-5. Epub 2014 Sep 9.
  532. Yu C, Xu Z, Long W, Longfei L, Feng Z, Lin Q, Xiongbing Z, Hequn C. Hemostatic agents used for nephrostomy tract closure after tubeless PCNL: a systematic review and meta-analysis. Urolithiasis. 2014 Oct;42(5):445-53. doi: 10.1007/s00240-014-0687-7. Epub 2014 Jul 27.
  533. Jiao B, Ding Z, Luo Z, Lai S, Xu X, Chen X, Zhang G. Single- versus Multiple-Tract Percutaneous Nephrolithotomy in the Surgical Management of Staghorn Stones or Complex Caliceal Calculi: A Systematic Review and Meta-analysis. Biomed Res Int. 2020 Dec 17;2020:8817070. doi: 10.1155/2020/8817070.
  534. Song R, Ji C, Cong R, Luan J, Yao L, Song N, Meng X. Is It Safe to Increase the Number of Percutaneous Nephrolithotomy Channels: A Systematic Review and Meta-Analysis. Arch Esp Urol. 2022 Dec;75(10):819-830. doi: 10.56434/j.arch.esp.urol.20227510.120.
  535. Yu J, Guo B, Yu J, Chen T, Han X, Niu Q, Xu S, Guo Z, Shi Q, Peng X, Deng Z, Yang P. Antibiotic prophylaxis in perioperative period of percutaneous nephrolithotomy: a systematic review and meta-analysis of comparative studies. World J Urol. 2020 Jul;38(7):1685-1700. doi: 10.1007/s00345-019-02967-5. Epub 2019 Sep 27.
  536. Danilovic A, Talizin TB, Torricelli FCM, Marchini GS, Batagello C, Vicentini FC, Nahas WC, Mazzucchi E. One week pre-operative oral antibiotics for percutaneous nephrolithotomy reduce risk of infection: a systematic review and meta-analysis. Int Braz J Urol. 2023 Mar-Apr;49(2):184-193. doi: 10.1590/S1677-5538.IBJU.2022.0544.
  537. Zhou G, Zhou Y, Chen R, Wang D, Zhou S, Zhong J, Zhao Y, Wan C, Yang B, Xu J, Geng E, Li G, Huang Y, Liu H, Liu J. The influencing factors of infectious complications after percutaneous nephrolithotomy: a systematic review and meta-analysis. Urolithiasis. 2022 Dec 14;51(1):17. doi: 10.1007/s00240-022-01376-5.
  538. Rui X, Hu H, Yu Y, Yu S, Zhang Z. Comparison of safety and efficacy of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy in patients with large renal pelvic stones: a meta-analysis. J Investig Med. 2016 Aug;64(6):1134-42. doi: 10.1136/jim-2015-000053. Epub 2016 May 24.
  539. Zhao C, Yang H, Tang K, Xia D, Xu H, Chen Z, Ye Z. Comparison of laparoscopic stone surgery and percutaneous nephrolithotomy in the management of large upper urinary stones: a meta-analysis. Urolithiasis. 2016 Nov;44(6):479-490. doi: 10.1007/s00240-016-0862-0. Epub 2016 Mar 2.
  540. Bai Y, Tang Y, Deng L, Wang X, Yang Y, Wang J, Han P. Management of large renal stones: laparoscopic pyelolithotomy versus percutaneous nephrolithotomy. BMC Urol. 2017 Aug 31;17(1):75. doi: 10.1186/s12894-017-0266-7.
  541. Mao T, Wei N, Yu J, Lu Y. Efficacy and safety of laparoscopic pyelolithotomy versus percutaneous nephrolithotomy for treatment of large renal stones: a meta-analysis. J Int Med Res. 2021 Jan;49(1):300060520983136. doi: 10.1177/0300060520983136.
  542. Mantica G, Balzarini F, Chierigo F, Keller EX, Talso M, Emiliani E, Pietropaolo A, Papalia R, Scarpa RM, Terrone C, Esperto F; European Society of Residents in Urology (ESRU) and Young Academic Urologists (YAU). The fight between PCNL, laparoscopic and robotic pyelolithotomy: do we have a winner? A systematic review and meta-analysis. Minerva Urol Nephrol. 2022 Apr;74(2):169-177. doi: 10.23736/S2724-6051.21.04587-0. Epub 2022 Feb 11.
  543. Chen Y, Feng J, Duan H, Yue Y, Zhang C, Deng T, Zeng G. Percutaneous nephrolithotomy versus open surgery for surgical treatment of patients with staghorn stones: A systematic review and meta-analysis. PLoS One. 2019 Jan 31;14(1):e0206810. doi: 10.1371/journal.pone.0206810.
  544. Gao ZM, Gao S, Qu HC, Li K, Li N, Liu CL, Zhu XW, Liu YL, Wang P, Zheng XH. Minimally invasive percutaneous nephrolithotomy improves stone-free rates for impacted proximal ureteral stones: A systematic review and meta-analysis. PLoS One. 2017 Feb 2;12(2):e0171230. doi: 10.1371/journal.pone.0171230.
  545. Wang Y, Chang X, Li J, Han Z. Efficacy and safety of various surgical treatments for proximal ureteral stone ≥10mm: A systematic review and network meta-analysis. Int Braz J Urol. 2020 Nov-Dec;46(6):902-926. doi: 10.1590/S1677-5538.IBJU.2019.0550.
  546. Lai S, Jiao B, Diao T, Seery S, Hu M, Wang M, Hou H, Wang J, Zhang G, Liu M. Optimal management of large proximal ureteral stones (>10 mm): A systematic review and meta-analysis of 12 randomized controlled trials. Int J Surg. 2020 Aug;80:205-217. doi: 10.1016/j.ijsu.2020.06.025. Epub 2020 Jul 1.
  547. Sharma G, Pareek T, Tyagi S, Kaundal P, Yadav AK, Thummala Y, Devana SK. Comparison of efficacy and safety of various management options for large upper ureteric stones a systematic review and network meta-analysis. Sci Rep. 2021 Jun 3;11(1):11811. doi: 10.1038/s41598-021-91364-3.
  548. Lifshitz DA, Lingeman JE. Ureteroscopy as a first-line intervention for ureteral calculi in pregnancy. J Endourol. 2002;16:19–22. https://doi.org/10.1089/089277902753483664
  549. Hoscan MB, Ekinci M, Tunckiran A, Oksay T, Ozorak A, Ozkardes H. Management of symptomatic ureteral calculi complicating pregnancy. Urology. 2012;80:1011–1014. https://doi.org/10.1016/j.urology.2012.04.039.
  550. Лачинов Э.Л., Жантлисов Д.А., Горбачев М.В. Коррекция рН мочи - эффективный инструмент успешной метафилактики мочекаменной болезни. Фитотерапия. Урология. 2020. № 3. С. 104-110
  551. Laerum E, Larsen S. Thiazide prophylaxis of urolithiasis. A double-blind study in general practice. Acta Med Scand. 1984;215(4):383-9. PMID: 6375276.
  552. Scholz D, Schwille PO, Sigel A. Double-blind study with thiazide in recurrent calcium lithiasis. J Urol. 1982 Nov;128(5):903-7. doi: 10.1016/s0022-5347(17)53269-3. PMID: 7176047.
  553. Y.A.Noureldin, A. da Silva, N.Fahmy, S.Andonian. Turk  Is it safe to prescribe ascorbic acid for urinary acidification in stone-forming patients with alkaline urine? J Urol 2017; 43(2): 183-8 • DOI: 10.5152/tud.2017.02700
  554. Inci K, Sahin A, Islamoglu E, Eren MT, Bakkaloglu M, Ozen H. Prospective long-term followup of patients with asymptomatic lower pole caliceal stones. J Urol. 2007 Jun;177(6):2189-92. doi: 10.1016/j.juro.2007.01.154. PMID: 17509315.; Lovegrove CE, Geraghty RM, Yang B,
  555. Brain E, Howles S, Turney B, Somani B. Natural history of small asymptomatic kidney and residual stones over a long-term follow-up: systematic review over 25 years. BJU Int. 2022 Apr;129(4):442-456. doi: 10.1111/bju.15522. Epub 2021 Sep 6. PMID: 34157218.,
  556. Han DS, Cher BAY, Lee D, Rajendran S, Riblet NBV, Pais VM Jr,. The Durability of Active Surveillance in Patients with Asymptomatic Kidney Stones: A Systematic Review. J Endourol. 2019 Jul;33(7):598-605. doi: 10.1089/end.2018.0695. Epub 2019 Jun 7. PMID: 31044612.].
  557. Саенко В.С., Песегов С.В., Фролова Е.А. Роль питьевых и диетических факторов в эффективном литолизе и метафилактике мочекислого нефролитиаза.   Урология, 2019, №2 с. 113-118
  558. Ferraro PM, Bargagli M, Trinchieri A, Gambaro G. Risk of Kidney Stones: Influence of Dietary Factors, Dietary Patterns, and Vegetarian-Vegan Diets. Nutrients. 2020 Mar 15;12(3):779. doi: 10.3390/nu12030779. PMID: 32183500; PMCID: PMC7146511.
  559. Wolfgram DF, Gundu V, Astor BC, Jhagroo RA. Hydrochlorothiazide compared to chlorthalidone in reduction of urinary calcium in patients with kidney stones. Urolithiasis. 2013 Aug;41(4):315-22. doi: 10.1007/s00240-013-0568-5. Epub 2013 May 10. PMID: 23660825.
  560. Lombardo R, Tzelves L, Geraghty R, Davis NF, Neisius A, Petřík A, Gambaro G, Türk C, Somani B, Thomas K, Skolarikos A. Follow-up of urolithiasis patients after treatment: an algorithm from the EAU Urolithiasis Panel. World J Urol. 2024 Mar 28;42(1):202. doi: 10.1007/s00345-024-04872-y. PMID: 38546854.
  561. Magni G, Unwin RJ, Moochhala SH. Renal tubular acidosis (RTA) and kidney stones: Diagnosis and management. Arch Esp Urol. 2021 Jan;74(1):123-128. English, Spanish. PMID: 33459628.
  562. Giglio S, Montini G, Trepiccione F, Gambaro G, Emma F. Distal renal tubular acidosis: a systematic approach from diagnosis to treatment. J Nephrol. 2021 Dec;34(6):2073-2083. doi: 10.1007/s40620-021-01032-y. Epub 2021 Mar 26. PMID: 33770395; PMCID: PMC8610947.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*